1. Introduction
Neurodegenerative diseases are a major challenge to global health, with a higher probability of occurrence in the elderly. These pathologies irreversibly affect neurons, affecting the quality of life of people and leading to a reduced life expectancy [1].
Plants have been intertwined with human civilization since ancient times, offering sustenance, healing, and cultural significance. However, the relationship between plants and the human brain remains relatively unexplored, rich with promise and danger. The brain, a marvel of complexity and fragility, is susceptible to degeneration over time, making the exploration of neuroprotective and neurotoxic compounds from plants a matter of essential importance [2]. The human brain, with its intricate network of neurons and neurotransmitters, requires meticulous care to function optimally, and plants, with their diverse array of bioactive phytoconstituents, possess the capacity to either bolster or undermine its performance [3]. The significance of investigating plants with neurological effects lies in the potential discovery of novel neuroprotective agents that could combat neurodegenerative diseases and enhance cognitive function [4]. Plants have been found to possess compounds that can protect neurons from damage caused by neurotoxins, reduce neuroinflammation, and even improve memory and cognitive abilities [5].
Numerous plant-derived compounds have been identified as powerful neuroprotective agents, offering a shield against neurological disorders and bolstering cognitive function [6]. They contribute to the strengthening of the human system and combat the various processes of nerve cell damage, thus supporting the proper functioning of the brain and stimulating brain regeneration [7]. For instance, studies have highlighted the neuroprotective properties of compounds found in plants like Hypericum perforatum, commonly known as St. John’s Wort, which have shown promise in mitigating neurotoxicity and potentially benefiting individuals with conditions like Alzheimer’s and Parkinson’s disease [8,9]. Moreover, plants like Melissa officinalis, Matricaria recutita, and Cymbopogon citratus have been studied for their antioxidant effects, which play a crucial role in mitigating oxidative stress in the brain. Oxidative stress is implicated in the pathogenesis of various neurological disorders, and the presence of antioxidants in these plants showcases their potential neuroprotective benefits. By scavenging free radicals and reducing lipid peroxidation, plant extracts can help maintain neuronal health and function, highlighting the dual role of plants in neurological outcomes [10]. Phytocompounds derived from medicinal herbs and dietary sources play a crucial role in maintaining the chemical balance of the brain by influencing the function of neurotransmitter receptors [11]. These compounds, such as polyphenolic compounds found in fruits, vegetables, herbs, and nuts, exhibit neuroprotective properties that can enhance memory and cognitive function [12]. Reactive oxygen species are responsible for most pathologies, which can be neutralized with plant polyphenolic compounds, which protect cellular functions [13]. Triterpenic acids, a class of phytocompounds with diverse therapeutic properties, including neuroprotective effects, have been extensively studied for their potential to address various health issues, including neurodegenerative diseases [14]. Plants like Gentiana olivieri contain phytocompounds such as gentiopicroside and isoorientin, which have demonstrated anti-inflammatory and antioxidant properties, contributing to their neuroprotective effects [15]. As oxidative stress is followed by lipid peroxidation, compounds with antioxidant action offer better protection against oxidative stress and damage [16]. Additionally, the activation of SIRT1 by resveratrol, a polyphenolic compound found in red grapes, has shown promising neuroprotective effects against oxidative stress and toxicity induced by amyloid-β peptides [17]. Studies have also emphasized the neuroprotective efficacy of phytoconstituents from plants like Calligonum polygonoides, with compounds such as apigenin triacetate showing interactions with key enzymes and receptors in the brain, leading to improvements in conditions like hypercholesterolemia and neurodegenerative changes in brain regions like the cortex and hippocampus [18].
Conversely, some plants contain neurotoxic substances that can disrupt the delicate balance of the brain, leading to cognitive decline, neurological damage, and in severe cases, life-threatening consequences [19]. For instance, the Veratrum species contains steroidal alkaloids that have been reported to cause DNA damage and decrease blood pressure in vivo. These alkaloids can have detrimental effects on the brain and overall neurological function [20]. Similarly, aconitine, a diterpenoid alkaloid found in Aconitum species, is known for its anti-inflammatory and analgesic properties but can also induce severe arrhythmia and neurotoxicity. The presence of aconitine highlights how certain plant compounds can have dual effects, including neurotoxic outcomes [21]. Moreover, plants like Lathyrus species contain β-N-oxalyl-L-α,β-diaminopropionic acid (BOAA), an acute neurotoxic agent that can lead to lathyrism, a neurological disorder associated with the consumption of these plants. The neurotoxic compound in Lathyrus plants is species-specific and has been linked to the development of neurolathyrism in individuals consuming these plants over extended periods [22,23]. Additionally, pyrrolizidine alkaloids (PAs), a group of secondary metabolites found in various plants, have been studied for their pharmacological applications but also pose risks due to their potential neurotoxic effects [24]. These examples underscore the diverse range of plants containing neurotoxic compounds that can adversely affect neurological health.
Furthermore, the impact of plant chemicals on neurological systems extends to interactions with neurotransmission pathways. Aconitine, for instance, disrupts serotonin neurotransmission via 5-hydroxytryptamine receptors in zebrafish embryos, indicating a direct effect on synaptic transmission. This disruption in neurotransmission highlights how plant-derived compounds can interfere with essential signaling processes in the brain, leading to neurotoxic outcomes [25]. Additionally, the presence of certain alkaloids in plants can have indirect neurotoxic effects. For example, some mushrooms and plants contain compounds like dencichine and cyanogens, which can exhibit neurotoxicity in humans due to their interaction with metal elements in the environment. This indirect neurotoxic potential emphasizes the complex interplay between plant chemicals, environmental factors, and neurological health [26].
The relationship between dosage and the neurotoxic or neuroprotective effects of plants is a fundamental principle in toxicology, famously articulated by Paracelsus: “The dose makes the poison” (Latin: “Sola dosis facit venenum”) [27,28]. This adage underscores that any substance can be both beneficial and harmful, depending on its concentration. Numerous studies have documented that various plant extracts exhibit neuroprotective properties at certain dosages while potentially being neurotoxic at others. For instance, compounds derived from plants have been shown to provide neuroprotection against neurodegenerative diseases when administered in appropriate amounts [29]. Conversely, excessive exposure to these same compounds can lead to adverse effects, highlighting the critical role of dosage in determining their therapeutic value [30]. Thus, understanding the dose–response relationship is essential for harnessing the therapeutic potential of plants while mitigating their risks [31].
This exploration of the dual nature of plants’ impact on the human brain aims to illuminate the intricate interplay between plants and neurological health. By unraveling the complexities of this relationship, we can harness the therapeutic potential of plants to enhance brain function while remaining vigilant against the risks plants may pose. Understanding the mechanisms underlying the neuropharmacological activities of the phytocompounds is crucial for unlocking their full therapeutic potential and advancing novel strategies for brain health and disease management.
The scope of this article extends to elucidating both the beneficial and detrimental effects of some plant species on the human brain, underscoring the critical need for a nuanced understanding of neurology for exploiting herbal medicine effectively. Through a comprehensive analysis of neuroactive compounds in different plant species, this article aims to emphasize the importance of using nature’s resources to improve neurological well-being. The findings presented in this article are poised to have far-reaching implications across diverse fields, from medicine and neuroscience to agriculture and environmental science, fostering a deeper understanding of the profound influence that plants wield over the human brain.
2. Neurotoxic Plants
2.1. Defining Neurotoxicity and Some Mechanisms of Plant-Induced Neurotoxicity
Neurotoxicity, in the context of plant-induced neurotoxicity, refers to the harmful effects that certain plants or their bioactive components can have on the nervous system. This phenomenon involves various mechanisms that can lead to damage or dysfunction in the nervous system, impacting both the peripheral and central nervous systems. Several studies have delved into the mechanisms underlying neurotoxicity caused by different plant-derived substances, shedding light on the intricate processes involved [32,33,34].
The mechanisms of plant-induced neurotoxicity are multifaceted and involve various pathways that can lead to detrimental effects on neuronal cells. One such mechanism involves the production of neurotoxic compounds that can disrupt normal neuronal function and lead to neurodegeneration. For example, bufadienolides found in some succulent plants from the Crassulaceae family (like Cotyledon, Tylecodon, or Kalanchoe) have been identified as neurotoxic substances that can induce damage to the nervous system. These compounds can interfere with mitochondrial function, leading to oxidative stress, neuroinflammation, and ultimately apoptosis, contributing to neurotoxicity [35]. Moreover, the neurotoxicity induced by certain plant-derived substances can manifest in various ways, affecting different aspects of neurological function. For instance, cardiac glycosides have been shown to produce marked neurotoxicity when administered intracerebroventricularly in animal models, highlighting the potent effects these compounds can have on the nervous system [34]. Certain plant-derived substances, such as alkaloids, have been shown to affect sodium channels in the nervous system, leading to neurotoxic effects. By targeting essential components of neuronal signaling, these compounds can disrupt the normal functioning of neurons and potentially cause damage to the brain [36]. Additionally, some plants contain phytocompounds that can induce neurotoxicity through mechanisms such as oxidative stress, mitochondrial dysfunction, and inflammation. These compounds may interfere with critical processes in the nervous system, ultimately resulting in neuronal damage and dysfunction [37].
In the context of neurodegenerative diseases, the role of mitochondria in generating reactive oxygen species (ROS) has been implicated in the pathogenesis of conditions like Parkinson’s and Alzheimer’s diseases [38]. Plant compounds that interfere with mitochondrial function or exacerbate ROS production can contribute to neuronal damage and accelerate the progression of neurodegenerative disorders. Moreover, the disruption of endoplasmic reticulum–mitochondria interactions by certain plant-derived substances can lead to neurotoxicity, as seen in the case of phthalates causing morphological changes and cognitive impairments in the brain [39,40].
Overall, some plants can exert brain-damaging effects and negatively impact the nervous system through the production of neurotoxic compounds that interfere with essential neuronal processes involving a variety of pathways that can lead to neuronal damage and cell death. From disrupting mitochondrial function and inducing oxidative stress to altering neurotransmitter levels and promoting neuroinflammation, some plant-derived substances can have diverse mechanisms of neurotoxicity. Understanding these mechanisms is important for identifying potential neurotoxic plants and developing strategies to mitigate their harmful effects.
2.2. Common Neurotoxic Plants—Mechanisms of Neurotoxicity, Symptoms of Neurotoxicity, Management of Neurotoxic Plant Poisoning
2.2.1. Aconitum Species (Monkshood)
Historical Background
Aconitum species, belonging to the Ranunculaceae family, have a long history of use in both Western and Eastern medicine for their pharmacological properties [41]. These plants are known for their rich content of diterpene alkaloids and flavonoids [42]. Aconitum alkaloids, particularly aconitine, are considered the characteristic bioactive ingredients of these species and are widely used in traditional medicine. Aconitine has been studied for its therapeutic potential in various conditions such as heart failure, myocardial infarction, neuroinflammatory diseases, rheumatic diseases, and tumors [43]. However, despite their medicinal uses, Aconitum species contain highly toxic compounds, especially in their tubers and flowers, which can have detrimental effects on the nervous system and cardiovascular system [44]. Aconitum presents a narrow therapeutic window, making it both beneficial and potentially lethal. Therapeutically, the doses of Aconitum preparations typically range from 1.5 to 3 g of the raw plant material, depending on the specific formulation and processing method [45,46,47]. However, the toxic and lethal doses are alarmingly close; the minimum lethal dose of aconitine, a principal alkaloid, is reported to be between 2 and 6 mg in humans [48,49]. Accidental overdoses can lead to severe symptoms such as bradycardia, hypotension, and potentially fatal arrhythmias, often resulting in death within 24 h due to cardiovascular collapse [50,51,52]. The therapeutic and toxic effects are compounded by the fact that improper processing of Aconitum can significantly increase its toxicity [45,53]. Therefore, careful dosage and processing are critical to mitigate the risks associated with Aconitum use.
Relevant Toxic Chemical Compounds, Mechanism of Toxicity
The main toxic compound found in Aconitum species is aconitine, a diester C19-diterpenoid alkaloid with potent neurotoxic effects [54]. Aconitine has been implicated in inducing cardiotoxicity, neurotoxicity, and mitochondrial damage in various studies [55]. It is known to affect the central nervous system and cardiovascular system, leading to symptoms such as polymorphic arrhythmias, neurotoxicity, hypotension, gastrointestinal disorders, paralysis, and even death [56,57]. The neurotoxic effects of aconitine have been linked to its ability to interfere with cellular signaling pathways, including the TNFα-NLRP3 signaling axis and mitophagy [55]. Additionally, aconitine has been shown to induce P-glycoprotein expression, potentially leading to drug–drug interactions and altered drug metabolism [58]. Another underlying mechanism of toxicity is based on the binding of aconitine to voltage-dependent sodium channels, favoring the influx of Na+ ions, concomitant with the increase in intracellular calcium via the Na+-Ca2+ exchange system [59]. Another diterpenoid alkaloid responsible for neurotoxicity is mesaconitine (MA), manifesting its damaging effects on neuronal cells via autophagy pathways [60].
Detoxification Process for Toxic Chemical Compounds, Mechanism of Toxicity
Studies have highlighted the importance of processing and detoxifying Aconitum species before use to mitigate their toxic effects [61]. Traditional methods like Śodhana in Ayurveda have been employed for detoxification and modification of the therapeutic activities of poisonous medicinal plants, including Aconitum species. The traditional Ayurvedic method of Śodhana involves a series of purification processes aimed at detoxifying toxic plants by reducing their toxicity and enhancing their therapeutic efficacy through the use of specific media such as cow’s milk, which facilitate the transformation of harmful constituents into less toxic forms [62,63,64,65]. This method not only purifies the physical and chemical properties of the plants but also minimizes side effects, thereby making them suitable for therapeutic applications [66,67,68].
These practices aim to reduce the concentration of toxic compounds, particularly alkaloids, which are responsible for the cardiotoxic and neurotoxic effects of Aconitum plants [62].
Poisoning
In cases of monkshood poisoning, which have been reported in various regions, the symptoms often involve neurological manifestations due to the toxic effects on the nervous system. The combination of Aconitum alkaloids with other substances like alcohol can exacerbate the toxicity, leading to central nervous system depression and neurological symptoms [69]. Management of neurotoxic plant poisoning involves supportive care, decontamination, and symptomatic treatment to address the effects on the nervous system and other affected organs [49]. The patient’s vital functions must be constantly checked, especially ventricular arrhythmias which can be treated with amiodarone and flecainide, which has been scientifically proven [51,70].
General Conclusion
Overall, Aconitum species, known for their medicinal properties, contain potent neurotoxic compounds such as aconitine that can harm the nervous system. Understanding the mechanisms of neurotoxicity, symptoms of poisoning, and appropriate management strategies is crucial in dealing with cases of Aconitum poisoning. Processing and detoxification methods play a significant role in reducing the toxic effects of Aconitum plants, emphasizing the importance of traditional practices in ensuring the safe use of these potent botanicals.
2.2.2. Atropa belladonna (Deadly Nightshade)
Historical Background
Atropa belladonna, commonly known as deadly nightshade, belongs to the Solanaceae family and has a long history of use in medicine due to its pharmacological properties. This plant contains a variety of alkaloids, with atropine and scopolamine being the most significant, responsible for its anticholinergic effects [71]. These alkaloids, along with hyoscyamine, exert both medicinal and toxic effects on the central and peripheral nervous systems [72]. Consumption of different parts of the Atropa belladonna plant, including the fruits, leaves, and roots, can lead to intoxication due to the presence of poisonous tropane alkaloids. Therapeutically, low doses of Atropa belladonna can be effective for conditions like asthma and gastrointestinal disorders due to its anticholinergic properties [73,74]. However, the line between therapeutic and toxic doses is narrow; even small amounts can lead to severe poisoning, particularly in children, where doses as low as 10–20 berries can be fatal [75,76]. For instance, atropine is utilized in doses as low as 0.5 to 1 mg for specific medical applications, such as treating bradycardia and as a pre-anesthetic agent [75]. Additionally, homeopathic preparations, such as those diluted to D3, contain minimal alkaloid concentrations, which may still provide therapeutic effects without significant toxicity [77].
Relevant Toxic Chemical Compounds, Mechanism of Toxicity
The chemical composition of Atropa belladonna, as analyzed in various studies, reveals the presence of tropane alkaloids, including hyoscyamine, atropine, and scopolamine, which contribute to its pharmacological properties. These alkaloids play a significant role in the plant’s toxic effects on the nervous system, leading to symptoms of poisoning when consumed [71,78]. The high alkaloid content in different parts of the Atropa belladonna plant underscores the potential dangers associated with its ingestion and the importance of recognizing and managing cases of poisoning effectively [78]. The neurotoxic effects of Atropa belladonna are primarily attributed to its alkaloid content, particularly atropine, and scopolamine, which act as anticholinergic agents [72]. These alkaloids interfere with the normal functioning of the cholinergic system in the body, leading to a range of symptoms associated with anticholinergic toxicity.
Poisoning
Atropa belladonna intoxication clinically manifests as anticholinergic syndrome, characterized by symptoms such as dry mouth, blurred vision, tachycardia, and altered mental status. Additionally, laboratory tests may show abnormalities reflecting the impact of the plant’s toxins on the body [78]. The hallucinogenic, sedative, and antiemetic effects are due to atropine’s ability to inhibit muscarinic acetylcholine receptors in the central nervous system, while the adverse effects of pupil dilation, decreased heart rate, and bronchial constriction occur as a result of blocking nerve impulses from the parasympathetic nervous system [79]. The management of Atropa belladonna poisoning involves various strategies to address the symptoms and effects of alkaloid toxicity. In cases of intoxication, especially in children where even small amounts can be fatal, prompt medical intervention is crucial [76]. Physostigmine, an acetylcholinesterase inhibitor, has been used in the treatment of Atropa belladonna poisoning to counteract the anticholinergic effects of the plant’s alkaloids. This antidote helps restore cholinergic activity in the body, mitigating the toxic effects of Atropa belladonna alkaloids on the nervous system [73].
General Conclusion
Atropa belladonna poses significant neurotoxic effects due to the presence of alkaloids, which exert anticholinergic actions on the nervous system. The plant’s historical uses in medicine are overshadowed by its potential for toxicity, leading to symptoms of poisoning when consumed. Management of Atropa belladonna poisoning involves prompt medical intervention, with physostigmine being used as an antidote to counteract the plant’s toxic effects. Understanding the neurotoxic implications of Atropa belladonna alkaloids is crucial for addressing their impact on the nervous system and potential implications for neurological disorders.
2.2.3. Conium maculatum (Hemlock)
Historical Background
Conium maculatum, commonly known as poison hemlock, belongs to the Apiaceae family and is notorious for its high toxicity due to the presence of piperidine alkaloids in its aerial parts [80]. The most significant alkaloid found in Conium maculatum is coniine, which can be fatal in doses as low as 150 mg, leading to neurotoxic effects, acute rhabdomyolysis, and acute renal failure [81]. Ingestion of larger amounts can be lethal, as evidenced by historical accounts and clinical cases [82]. Historically, Conium maculatum has been used in medicine for various purposes. It has been reported to possess antispasmodic properties and has been used to alleviate conditions such as epilepsy, asthma, angina, rheumatism, and tetanus [83]. Additionally, the plant has been utilized in traditional and alternative medicine systems, including homeopathy, for treating glandular enlargements and cancerous tumors in various parts of the body [84]. The plant’s toxic nature has also been recognized for its acute toxicity to humans and domestic animals globally [85].
Relevant Toxic Chemical Compounds, Mechanism of Toxicity
The chemical composition of Conium maculatum includes a range of secondary metabolites, such as alkaloids, flavonoids, coumarins, polyacetylenes, and non-volatile oils [80]. Among these compounds, alkaloids have been identified as bioactive constituents in the plant. The presence of alkaloids like coniine in Conium maculatum has been linked to its toxic effects on the nervous system and overall neurotoxicity [86]. Other alkaloids present in the plant include N-methylconiine, conhydrine, pseudoconhydrine, and γ-coniceine [87]. These alkaloids, particularly γ-coniceine and coniine, are responsible for the plant’s toxicity and are known to have stereoselective potencies and relative toxicities [88]. The neurotoxic effects of Conium maculatum, particularly attributed to coniine, are mediated through its interaction with nicotinic acetylcholine receptors (nAChRs). Coniine acts as an agonist of nAChRs, leading to the activation of these receptors and subsequent effects on muscle movement and function. Studies have shown that coniine can activate fetal muscle-type nAChRs and inhibit fetal movement, highlighting its potent neurotoxic properties [89].
Poisoning
Symptoms of neurotoxicity or brain damage resulting from Conium maculatum poisoning may include respiratory failure, muscle weakness, paralysis, tremors, seizures, and ultimately death in severe cases. The neurotoxic effects of the plant’s alkaloids can manifest as progressive paralysis starting from the lower extremities and moving upwards, eventually affecting respiratory muscles and leading to respiratory failure. Management of neurotoxic plant poisoning, such as that caused by Conium maculatum, involves supportive care and symptomatic treatment. In cases of ingestion or exposure to the plant, it is crucial to seek immediate medical attention. Treatment may include respiratory support, administration of activated charcoal to limit further absorption of toxins, intravenous fluids for hydration, and in severe cases, the use of antidotes if available. Close monitoring of vital signs, neurological status, and respiratory function is essential in managing cases of Conium maculatum poisoning [81].
General Conclusion
Conium maculatum, with its potent neurotoxic alkaloids like coniine, poses a significant risk to human health. The plant’s historical uses in medicine, chemical composition rich in toxic alkaloids, mechanisms of neurotoxicity through nAChR activation, and symptoms of neurotoxicity, and the management of plant poisoning, highlight the importance of understanding and addressing the dangers associated with this toxic plant. Effective management of Conium maculatum poisoning requires prompt medical intervention and supportive care to mitigate the potentially severe consequences of neurotoxicity and brain damage resulting from exposure to this plant.
2.2.4. Oenanthe crocata (Hemlock Water-Dropwort)
Historical Background
Oenanthe crocata, commonly known as hemlock water-dropwort, belongs to the Apiaceae family and is recognized for its potent neurotoxic effects [90]. The inhibition of GABA receptors by polyacetylenes extracted from Oenanthe fistulosa, closely related to Oenanthe crocata, further supports the mechanism through which these compounds affect the nervous system [91].
Relevant Toxic Chemical Compounds, Mechanism of Toxicity
This plant contains neurotoxins such as oenanthotoxin, dihydrooenanthotoxin, and cicutoxin, which have been identified as the compounds responsible for its toxic properties [92]. These neurotoxins have been found to block GABAergic responses, leading to symptoms such as facial muscle paralysis, which can manifest as a strained smile [93]. The chemical composition of Oenanthe crocata includes polyacetylenes, which have been shown to have inhibitory effects on GABA receptors [91]. Additionally, the essential oil of Oenanthe crocata has been found to contain compounds like sabinene, which exhibit antioxidant, antifungal, and anti-inflammatory activities [94]. These chemical constituents play a role in the plant’s overall toxicity and its impact on the nervous system. Furthermore, the presence of the convulsant polyacetylene toxin oenanthotoxin in water hemlock, a plant closely related to Oenanthe crocata, highlights the shared neurotoxic properties within the genus [95].
Poisoning
Symptoms of neurotoxicity or brain damage resulting from Oenanthe crocata poisoning can include autonomic dysfunction, heart issues, and potentially fatal outcomes such as heart arrest. The reversible nature of autonomic dysfunction in Oenanthe crocata poisoning suggests that prompt management and intervention can lead to recovery in affected individuals [96]. Moreover, the potent neurotoxic effects of Oenanthe crocata, attributed to compounds like oenanthotoxin and dihydrooenanthotoxin, underscore the importance of understanding the plant’s toxic properties and implementing appropriate treatment strategies in cases of poisoning [92]. Management of neurotoxic plant poisoning, such as that caused by Oenanthe crocata, involves supportive care to address the symptoms presented by the affected individual. This may include measures to stabilize vital signs, manage any cardiovascular complications, and provide symptomatic treatment to alleviate the effects of neurotoxins on the body. Additionally, in cases of severe poisoning, interventions such as decontamination and administration of antidotes may be necessary to counteract the toxic effects of the plant compounds and prevent further damage to the nervous system [96].
General Conclusion
Oenanthe crocata poses significant risks due to its neurotoxic effects, primarily mediated by compounds like oenanthotoxin and dihydrooenanthotoxin. These substances interfere with GABAergic responses, leading to symptoms such as facial muscle paralysis. Understanding the chemical composition, mechanisms of neurotoxicity, symptoms of poisoning, and appropriate management strategies is crucial in dealing with cases of Oenanthe crocata poisoning and mitigating its damaging effects on the nervous system. Vigilance in recognizing and treating plant poisonings, particularly those involving potent neurotoxins like the ones from Oenanthe crocata, is essential to ensure favorable outcomes for affected individuals.
2.2.5. Ricinus communis (Castor Plant)
Historical Background
Ricinus communis, commonly known as the castor oil plant, belongs to the Euphorbiaceae family and has a long history of medicinal use [97]. The neurotoxic effects of Ricinus communis have been studied extensively, particularly focusing on its impact on the nervous system [98].
Relevant Toxic Chemical Compounds, Mechanism of Toxicity
The chemical composition of Ricinus communis plays a crucial role in its neurotoxicity. The plant contains various bioactive compounds such as ricinoleic acid, tannins, flavonoids, cardiac glycosides, steroids, saponins, alkaloids, phlorotannins, and terpenoids, which have been associated with various toxic effects, including neurotoxicity [99,100]. One of the most notorious components of Ricinus communis is ricin, a potent toxin attributed to the lectin ricin. Ricin, in particular, has been extensively studied for its ability to inhibit protein synthesis, leading to cell death and tissue damage [101]. Ricin is a 60 to 65 kDa glycoprotein that acts as a lectin and belongs to the A-B toxin family. The lectin ricin, derived from Ricinus communis, shares sequence homology with ribosome-inactivating proteins, further elucidating its mechanism of action in disrupting cellular processes [102]. Ricinus communis has been found to have neurotoxic effects due to compounds like ricin, which can lead to severe damage to the nervous system. The neurotoxic effects of Ricinus communis are attributed to its agglutinin-II component, which has been shown to have detrimental impacts on neural tissues [103].
Poisoning
Symptoms of neurotoxicity or brain damage from Ricinus communis poisoning may include nausea, vomiting, abdominal pain, diarrhea, seizures, and, in severe cases, respiratory failure and death. The toxic effects on the nervous system can manifest as neurological symptoms such as confusion, dizziness, and muscle weakness. Additionally, exposure to Ricinus communis can lead to organ damage, particularly affecting the liver and kidneys, further exacerbating the toxic effects on the body. Management of neurotoxic plant poisoning, such as that caused by Ricinus communis, involves supportive care and specific treatments to counteract the effects of the toxins. In cases of ingestion, decontamination methods like gastric lavage or administration of activated charcoal may be employed to reduce further absorption of the toxins. Symptomatic treatment to address specific symptoms such as seizures or respiratory distress is crucial in managing cases of neurotoxicity from plant poisoning. In severe cases, antidotes or specific therapies targeting the toxins’ mechanisms of action may be considered to mitigate the toxic effects on the nervous system [101].
General Conclusion
Ricinus communis, with its complex chemical composition containing toxic compounds like ricin, poses significant risks to the nervous system and overall health. The plant’s neurotoxic effects are well documented, highlighting the importance of understanding its mechanisms of action, symptoms of toxicity, and appropriate management strategies in cases of poisoning. Further research into the specific pathways through which Ricinus communis exerts its neurotoxic effects is essential for developing targeted interventions to mitigate its damaging impacts on the nervous system.
Figure 1 illustrates the mechanisms of action of some neurotoxic plants, including the Latin names of the plants, their major toxic compounds, the specific mechanisms of neurotoxicity, and the resultant effects on the nervous system. This overview provides insights into how these plants exert their neurotoxic effects, aiding in understanding the potential risks associated with exposure to these botanical sources of toxicity.
Table 1 systematically categorizes various neurotoxic plants, detailing their respective used parts and the toxic secondary metabolites identified within them. Each entry elucidates the mechanism of toxicity associated with the metabolites, providing insight into how these compounds exert their neurotoxic effects. The table further distinguishes between in vivo models utilized in the studies, specifying the lethal dosages administered in each case. The outcomes of the toxicity assessments are succinctly summarized, highlighting the effects observed in the experimental models. This comprehensive overview serves as a valuable resource for understanding the neurotoxic potential of these plants and the underlying biological mechanisms involved.
Table 1Overview of neurotoxic plants: used parts, toxic secondary metabolites, in vivo studies and toxic dosage, and outcomes.
| Plant, Family | Used Parts | Toxic Secondary Metabolites | In Vivo Studies and Toxic Dosage | Outcomes | Refs. | |
|---|---|---|---|---|---|---|
| Aconitum napellus (monkshood), Ranunculaceae | Roots, leaves | diterpenoid alkaloids: aconitine, mesaconitine, hypaconitine, benzoylaconitine, benzoylmesaconine, benzoylhypaconine, lappaconitine, jesaconitine, songorine, heteratisine, napelline | Aconitine | Mouse: 1.8 mg/kg (p.o.), 0.24–0.55 mg/kg (s.c.), 0.28–0.34 mg/kg (i.p.), 0.12 mg/kg (i.v.) | Aconitum poisoning disrupts the neural transmission pathway, preventing normal neuronal signals from traversing the synapse, leading to abnormal limb control, paralysis, dizziness, speech difficulties, muscle weakness, twitching, and spasms. Furthermore, the toxic compounds can inflict damage on the central nervous system, potentially causing both temporary and long-lasting neurological disorders, and in severe cases, this condition may culminate in shock or coma. | [51,104] |
| Rat: 0.102- 0.112 mg/kg (i.v.) | ||||||
| Cat: 0.07–0.13 mg/kg (i.v.) | ||||||
| Dog: 0.5 mg/kg (i.v.) | ||||||
| Human: 2–5 mg (p.o.) | ||||||
| Mesaconitine | Mouse: 1.9 mg/kg (p.o.), 0.19–0.25 mg/kg (s.c.), 0.20–0.23 mg/kg (i.p.), 0.068–0.10 mg/kg (i.v.) | |||||
| Rat: 0.158 mg/kg (i.v.) | ||||||
| Hypaconitine | Mouse: 5.8 mg/kg (p.o.), 1.1–1.9 mg/kg (s.c.), 1.0–1.2 mg/kg (i.p.), 0.47 mg/kg (i.v.) | |||||
| Rat: 0.291 mg/kg (i.v.) | ||||||
| Benzoylaconine | Mouse: 70 mg/kg (i.p.), 23 mg/kg (i.v.) | |||||
| Rat: > 20.2 mg/kg (i.v.) | ||||||
| Benzoylmesaconine | Mouse: 810 mg/kg (p.o.), 230 mg/kg (s.c.), 240 mg/kg (i.p.), 21 mg/kg (i.v.) | |||||
| Rat: > 18.7 mg/kg (i.v.) | ||||||
| Benzoylhypaconine | Mouse: 830 mg/kg (p.o.), 130 mg/kg (s.c.), 120 mg/kg (i.p.), 23 mg/kg (i.v.) | |||||
| Rat: > 20.4 mg/kg (i.v.) | ||||||
| Lappaconitine | Mouse: 5.9–11.5 mg/kg (i.v.) | |||||
| Jesaconitine | Mouse: 0.23 mg/kg (s.c.) | |||||
| Songorine | Mouse: 106 mg/kg (i.v.) | |||||
| Heteratisine | Mouse: 147 mg/kg (i.v.) | |||||
| Napelline | Mouse: > 147 mg/kg (i.v.) | |||||
| Atropa belladonna (deadly nightshade), Solanaceae | Leaves, roots, berries | tropane alkaloids: hyoscyamine, atropine, scopolamine | The lethal quantity: >2–4 mg/day | The anti-muscarinic effects of Atropa belladonna poisoning result in a range of symptoms, including confusion, incomprehensible speech, delirium, lethargy, coma, palpitations, flushing, mydriasis, blurred vision, and hallucinations. The anticholinergic properties of these compounds inhibit the action of acetylcholine at muscarinic receptors, leading to the aforementioned neurological and cardiovascular disturbances. | [81,105,106] | |
| Conium maculatum (hemlock), Apiaceae | Leaves, seeds | piperidine alkaloids: coniine, γ-coniceine | Rat: >50 mg/kg (p.o.) | Conium maculatum poisoning presents with a sequence of clinical manifestations, beginning with heightened activity of motor nerve endings and the central nervous system. This initial stimulation is succeeded by paralysis and a state of depression, leading to impaired movement characterized by slowness and weakness. Subsequently, affected individuals may experience a rapid pulse, hyperventilation, increased urination, respiratory paralysis, and ultimately progress to coma and death. In the initial phase of poisoning, symptoms such as ataxia and headache are evident, whereas heightened salivation, rapid heart rate, and dilation of the pupils arise as a result of the plant’s impact on the autonomic ganglia. | [107,108,109] | |
| Coniine | Mouse: 100 mg/kg (p.o.), 19 mg/kg (i.v.); 80 mg/kg (s.c.) | |||||
| γ-coniceine | Mouse: 12 mg/kg (p.o.), 2.6 mg/kg (i.v.); 12 mg/kg (s.c.) | |||||
| Oenanthe crocata (hemlock water-dropwort), Apiaceae | Tubers, leaves, seeds | polyacetylenes: oenanthotoxin, dihydrooenanthotoxin, cicutoxin | Mouse: 17 mg/kg for tubers, 1320 mg/kg for green seeds | The toxicity of Oenanthe crocata is associated with the induction of respiratory paralysis and convulsions, characterized by seizures that occur alongside a depression of motor functions within the central nervous system. This dual manifestation highlights the compound’s detrimental effects on both respiratory and neurological systems. | [110,111,112] | |
| Ricinus communis (castor plant), Euphorbiaceae | Seeds, leaves | ricin | Mouse: 30 mg/kg (p.o.), 22 mg/kg (i.p.); 2–10 mg/kg (i.v.), 3.5 µg crude ricin/kg BW (intranasal)—24 μg/kg (injection or inhalation), 20–30 mg/kg (seed ingestion) | Ricin exerts significant neurotoxic effects primarily through its mechanism of action as an inhibitor of protein synthesis. Upon exposure, ricin can lead to a range of neurological symptoms, including seizures, ataxia, and altered mental status. The toxin disrupts cellular function by enzymatically inactivating ribosomal RNA, which impairs protein synthesis and ultimately results in cell death, particularly in neurons. | [113,114,115] | |
p.o. = per os; s.c. = subcutaneously; i.p. = intraperitoneally; i.v. = intravenously.
Table 2 presents the chemical structures of primary secondary metabolites identified in various neurotoxic plants, presenting their structural diversity and highlighting their significance in neurotoxicity.
3. Neuroprotective Plants
3.1. Defining Neuroprotection and Some Mechanisms of Plant-Induced Neuroprotection
Neuroprotection, in the context of plant-induced effects, refers to the ability of certain compounds derived from medicinal plants and herbal extracts to shield neurons from damage or degeneration, thereby preserving their structure and function. These neuroprotective effects are crucial in combating various neurodegenerative conditions such as Parkinson’s disease (PD), Alzheimer’s disease (AD), stroke, and traumatic brain injuries [116,117,118].
Plants exhibit neuroprotective effects through various mechanisms that involve combating neuroinflammation and oxidative stress and correcting neurotransmitter imbalances. These mechanisms are crucial in maintaining neurological health and protecting against neurodegenerative disorders. Medicinal plants have been found to inhibit the accumulation of protein-based deposits, reduce oxidative stress, alleviate neuroinflammation, and address neurotransmitter deficiencies like acetylcholine and dopamine [119,120,121]. Phytochemicals play a significant role in these neuroprotective effects by acting as antioxidants, anti-inflammatories, anti-apoptotic agents, and inhibitors of enzymes like acetylcholinesterase and monoamine oxidase. Additionally, they exhibit neurotrophic activities that support the growth and survival of neurons [120].
Various plant extracts target different pathways associated with neurodegenerative diseases to provide neuroprotection. These pathways include inhibiting enzymes responsible for neurotransmitter degradation, reducing oxidative stress, preventing amyloid plaque formation, and enhancing mitochondrial function [121]. The neuroprotective effects of plants extend to central nervous system injuries, where compounds derived from plants have shown promise in modulating inflammatory responses, preserving tissues, and aiding in the recovery of motor and cognitive functions. This highlights the diverse ways in which plant-derived compounds can support neuronal health and function [122].
Compounds like ellagic acid, found in fruits and nuts, have been shown to protect dopamine neurons by inhibiting inflammatory processes in microglia [123]. Similarly, flavonoids like quercetin possess free radical scavenging abilities that contribute to neuroprotection by modulating intracellular signals to promote cellular survival [124].
One of the well-studied plant compounds with neuroprotective effects is resveratrol, a compound present in red grapes, known for its neuroprotective potential in conditions like stroke and traumatic brain injury [117]. Moreover, natural products like formononetin, a type of isoflavonoid, have shown promise in preventing and treating neurological diseases due to their beneficial biological activities [125]. These plant-derived compounds act through various pathways to protect neurons from damage, enhance cognitive function, and promote overall brain health [126].
The neuroprotective effects of plant compounds extend beyond traditional medicinal herbs to include fruits like Schisandra, which contain lignans known for their antioxidant and neuroprotective properties [127,128]. Additionally, extracts from plants such as Astragalus and Rhodiola have been found to protect against neurodegeneration and enhance cognitive function [129,130].
Furthermore, the neuroprotective properties of plant-derived compounds are not limited to specific conditions but have broad implications for overall brain health and function. For example, compounds like salidroside, found in Rhodiola plants, exhibit neuroprotective effects by reducing oxidative stress and promoting cell survival [129,131]. Similarly, the aqueous extract of Areca catechu has shown significant neuroprotective activity against H2O2-induced cell death in neurons, highlighting the potential of plant-based interventions in preventing neuronal damage [132].
Phenolic compounds found in plants have been extensively studied for their neuroprotective effects. Compounds like resveratrol, curcumin, apocynin, and epi-gallocatechin have shown significant neuroprotective properties. These compounds, derived from sources like grapes, Curcuma longa, Picrorhiza kurroa, and Camellia sinensis, exhibit antioxidant properties that are beneficial in conditions such as Alzheimer’s disease, Parkinson’s disease, and stroke [133]. Moreover, dietary plant polyphenols have been identified as safe agents with potent neuroprotective effects against various neurodegenerative diseases. These findings underscore the potential of plant-based polyphenols in supporting brain health and combating neurodegeneration [134]. Polyphenolic compounds, particularly flavonoids, have been identified as potent neuroprotective agents that offer protection against neonatal hypoxic–ischemic brain injury [135]. Interestingly, some plant extracts have demonstrated neuroprotective effects by mitigating neurotoxicity-induced damage in neuronal cells. For instance, extracts from plants like Centella asiatica, Panax ginseng, and Gastrodia elata have shown neuroprotective properties in cell culture models, suggesting a potential therapeutic role in combating neurotoxicity [4,136]. The neuroprotective activities of asiaticoside, madecassoside, and other plant compounds further demonstrate the therapeutic properties of plant-derived agents in supporting neurological health [137].
The diverse mechanisms of action of plant-derived compounds make them promising candidates for neuroprotection. For instance, neuroprotective phenylpropanoids like caffeic acid have been shown to reverse neurotoxicity induced by amyloid (A)β, highlighting their potential to mitigate neurodegenerative processes [138]. Additionally, pyranocoumarins from Angelica gigas demonstrate neuroprotective effects through activities such as free radical scavenging and modulation of apoptotic pathways [139,140]. Cannabis sativa contains compounds like Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) that possess anti-neuroinflammatory and neuroprotective activities [141]. Furthermore, compounds from natural sources, such as zonarol from brown algae, activate pathways like Nrf2/ARE to provide neuroprotection. The activation of such pathways is crucial in enhancing cellular defense mechanisms against oxidative stress and promoting neuronal survival [142]. The neuroprotective effects of compounds like polyprenylated tetraoxygenated xanthones from Hypericum monogynum roots highlight the diverse sources of neuroprotective agents found in plants [143].
Limonene, a compound found in various plants, has been shown to counteract neurotoxicity triggered by Aβ1–42 oligomers, highlighting its neuroprotective potential [144]. Similarly, Syzygium species have been found to exert neuroprotective effects by modulating various pathways such as cholinergic transmission, inflammation, oxidative stress, and antioxidant enzyme activity [145].
Plant-derived neuroprotective agents act through multiple mechanisms to interrupt the cycle of cell death and promote neuronal survival [146]. Compounds like carvacrol and p-cymene exhibit anti-enzymatic properties and neuroprotective effects against oxidative stress, emphasizing their potential in preserving neuronal function [147]. Flavonoids and diarylheptanoids, important phenolic compounds in plants, play a crucial role in imparting neuroprotective effects through their antioxidant and anti-inflammatory properties [148]. The neuroprotective potentials of extracts from the Amaryllidaceae plant family and their alkaloids further highlight the diverse sources of neuroprotective agents found in nature [149].
Phytoestrogens have been studied for their neuroprotective and neurotrophic efficacy in cultured hippocampal neurons, showcasing their potential to promote cell survival and protect against neurotoxic insults [150].
These examples collectively illustrate the vast array of plant-derived compounds that exhibit neuroprotective effects through various mechanisms, highlighting their potential in preventing and managing neurodegenerative disorders.
3.2. Common Neuroprotective Plants—Mechanisms of Neuroprotection, Neurological Benefits, Clinical Applications, and Research Findings
3.2.1. Ginkgo biloba (Ginkgo)
Historical Background
Ginkgo biloba, a plant from the Ginkgoaceae family, has a long history of use in traditional medicine and is known for its neuroprotective effects. The neuroprotective properties of Ginkgo biloba are attributed to various mechanisms of action, including antioxidation, anti-inflammation, anti-apoptosis, defense against mitochondrial dysfunction, modulation of tau protein phosphorylation, ion homeostasis, and the induction of growth factors. These mechanisms collectively contribute to the plant’s ability to protect neurons from damage and degeneration, making it a promising candidate for the treatment of neurodegenerative diseases [151].
Neuroprotective Chemical Metabolites
The chemical composition of Ginkgo biloba plays a crucial role in mediating its neuroprotective effects. The plant contains bioactive compounds such as flavonoids and terpenes, including ginkgolides and bilobalides, which contribute to its pharmacological properties. These compounds exert various actions, such as antioxidant, anti-inflammatory, and neuroprotective effects, which collectively enhance the plant’s therapeutic potential in neurological disorders [152].
Neuroprotective Properties
Research has shown that Ginkgo biloba extract, particularly the special extract EGb 761, demonstrates neuroprotective effects in neurodegenerative diseases with multifactorial origins [153]. Studies have highlighted the plant’s potential in mitigating Alzheimer’s disease-like pathologies, such as amyloid-β accumulation and neuronal loss, suggesting that Ginkgo biloba extract could serve as a prophylactic target for Alzheimer’s disease [154]. Additionally, Ginkgo biloba has been reported to reverse amyloid β-peptide-induced isoprostane production in the brain, emphasizing its role in ameliorating neurodegenerative changes associated with aging through its antioxidant effects [155].
Clinical Applications
The neuroprotective effects of Ginkgo biloba extend beyond Alzheimer’s disease, with studies indicating its potential in treating various neurological conditions. For instance, Ginkgo biloba has been found to have beneficial effects on memory and cognitive function in healthy older individuals and patients with dementia [156]. Furthermore, the plant has shown promise in treating attention-deficit disorder and other neuropsychiatric symptoms [157]. These findings underscore the diverse neurological benefits of Ginkgo biloba and its potential applications in enhancing brain health and function.
In addition to its neurological benefits, Ginkgo biloba has been investigated for its cardiovascular and renal protective effects. Studies suggest that the plant may have cardioprotective properties, including antioxidant, antiplatelet, antithrombotic, and vasodilatory effects, which could contribute to its potential in managing hypertension and related cardiovascular conditions [158]. Moreover, Ginkgo biloba extract has been identified as an effective antioxidant and free radical scavenger, highlighting its nephroprotective potential in combating oxidative stress-induced renal damage [159].
Clinical applications of Ginkgo biloba in the management of neurodegenerative diseases, cognitive impairment, and other neurological conditions have been supported by research findings. Meta-analyses and systematic reviews have synthesized the efficacy and safety of Ginkgo biloba extract in treating dementia, including Alzheimer’s disease and vascular dementia. These studies have highlighted the plant’s ability to improve cognitive function, memory, and overall brain health, making it a valuable therapeutic option for individuals with neurological disorders [160].
General Conclusion
Ginkgo biloba stands out as a natural remedy with significant neuroprotective effects attributed to its diverse mechanisms of action and bioactive compounds. From its historical uses in traditional medicine to its current applications in clinical practice, Ginkgo biloba continues to be a subject of interest in neuroscience research. The plant’s ability to safeguard neurons, enhance cognitive function, and protect against neurodegenerative processes underscores its potential as a valuable asset in the field of neuroprotection and neurological health.
3.2.2. Centella asiatica (Gotu Kola)
Historical Background
Centella asiatica, commonly known as gotu kola, belongs to the Apiaceae family and has a long history of traditional medicinal use [161]. This herb has gained recognition for its diverse pharmacological properties, including anti-inflammatory, antioxidant, and neuroprotective effects [162]. The neuroprotective potential of Centella asiatica has been a subject of interest in scientific research due to its ability to mitigate oxidative stress, inflammation, and cellular damage in various conditions [163]. The plant’s chemical composition, rich in triterpenes like asiaticoside and madecassoside, flavonoids, and other bioactive compounds, contributes to its therapeutic effects [164].
Neuroprotective Chemical Metabolites
Centella asiatica stands out as a botanical agent with profound neuroprotective effects attributed to its antioxidant, anti-inflammatory, and anti-apoptotic properties. The plant’s rich chemical composition, including triterpenes and flavonoids, contributes to its therapeutic potential in safeguarding neuronal health and function. From mitigating oxidative stress and inflammation to supporting nerve regeneration and cognitive function, Centella asiatica offers a holistic approach to neurological well-being. Further research and clinical trials are warranted to fully elucidate the mechanisms of action and optimize the therapeutic use of this botanical marvel in neurological disorders and neurodegenerative conditions [165].
Neuroprotective Properties
Studies have demonstrated that Centella asiatica exhibits significant neuroprotective effects through various mechanisms. One such mechanism involves its ability to modulate oxidative stress by enhancing antioxidant defenses and reducing lipid peroxidation [165]. Additionally, Centella asiatica has been shown to regulate inflammatory mediators, such as interleukins and tumor necrosis factor, thereby attenuating inflammation-induced neuronal damage [166]. The herb’s constituents, particularly asiaticoside, have been found to inhibit cell death pathways, including the expression of caspase-3, in the brain, highlighting its anti-apoptotic properties [167].
Clinical Applications
The neuroprotective benefits of Centella asiatica extend to neurological disorders and conditions. Research has indicated its potential to ameliorate neurological dysfunction under hypoxic conditions, suggesting a protective role in oxygen-deprived environments [168]. Furthermore, Centella asiatica has shown promise in addressing cognitive disorders, neurodegenerative diseases like Alzheimer’s and Parkinson’s, and even peripheral nerve injuries [169,170]. The herb’s ability to promote nerve regeneration and support neurodifferentiation of mesenchymal stem cells underscores its therapeutic versatility in neurological health [170].
General Conclusion
Clinical applications of Centella asiatica in neuroprotection have been explored in various contexts. Studies have highlighted its efficacy in reducing oxidative stress and improving cognitive function, making it a potential candidate for managing age-related cognitive decline and memory impairment [171]. Furthermore, the herb has demonstrated anti-seizure properties, suggesting a role in managing conditions like epilepsy [172]. Centella asiatica’s ability to enhance neuronal differentiation and protect against neurotoxic insults positions it as a valuable natural remedy for promoting brain health and resilience [173].
3.2.3. Panax ginseng (Ginseng)
Historical Background
Panax ginseng, a perennial plant from the Araliaceae family, has a rich history of medicinal use dating back thousands of years in traditional Chinese medicine as a tonic and prophylactic agent [174,175]. Modern research has explored the health benefits of Panax ginseng, revealing its potential neuroprotective effects. The plant contains bioactive compounds known as ginsenosides, which have been linked to many of its therapeutic properties [176]. Studies have demonstrated that these ginsenosides play a crucial role in the neuroprotective mechanisms of Panax ginseng [177].
Neuroprotective Chemical Metabolites
The chemical composition of Panax ginseng, particularly its ginsenosides, plays a remarkable role in its diverse therapeutic effects. These bioactive compounds have been extensively studied for their pharmacological activities, including their neuroprotective mechanisms [178]. The ginsenosides present in Panax ginseng have been linked to its ability to improve cognitive function, protect against neurodegeneration, and alleviate symptoms of various neurological disorders [174].
Neuroprotective Properties
The neuroprotective effects of Panax ginseng are attributed to its ability to scavenge free radicals and induce enzymes like superoxide dismutase and glutathione peroxidase, which help protect against oxidative stress and neuronal damage [177]. Additionally, Panax ginseng has been found to modulate the RAGE/NF-κB pathway, reducing oxidative stress and inflammation in the brain and thereby improving cognitive deficits induced by advanced glycation end products [178]. These mechanisms contribute to the plant’s overall neuroprotective properties.
Clinical Applications
Neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases, present significant challenges in healthcare. Research suggests that Panax ginseng and its bioactive components show promise in the treatment and prevention of these conditions [176]. Ginsenoside Rb1, a key active ingredient in Panax ginseng, has been specifically highlighted for its neuroprotective mechanisms in various central nervous system diseases [175]. This compound showcases the potential of Panax ginseng in mitigating neurological damage and related pathologies [174].
Clinical studies have further supported the neurological benefits of Panax ginseng. Research indicates that Panax ginseng supplementation can enhance cognitive performance in patients with Alzheimer’s disease [179]. The plant’s neuroprotective effects extend beyond cognitive enhancement to include the prevention and treatment of various neurodegenerative diseases [176]. Moreover, Panax ginseng has been found to protect against mercury-induced neurotoxicity, highlighting its potential to mitigate the harmful effects of heavy metal exposure on the central nervous system [180].
In addition to its neuroprotective effects, Panax ginseng exhibits a wide range of pharmacological activities. The plant has been reported to have anti-inflammatory, antioxidative, and anti-fibrotic properties, making it beneficial for various organ systems, including the liver, lung, heart, and kidney [181]. Furthermore, Panax ginseng has been shown to enhance muscle recruitment, reduce perceived effort during exercise, and accelerate muscle force recovery in athletes, indicating its potential in sports medicine and performance enhancement [182].
General Conclusion
Panax ginseng, with its rich history in traditional medicine and extensive modern research backing its therapeutic properties, stands out as a promising natural remedy with significant neuroprotective effects. The plant’s bioactive compounds, particularly ginsenosides, contribute to its diverse pharmacological activities, including its ability to protect against neurodegenerative diseases, enhance cognitive function, and mitigate neuronal damage. Clinical studies have provided evidence of Panax ginseng’s efficacy in improving neurological health, making it a valuable candidate for the prevention and treatment of various central nervous system disorders.
3.2.4. Withania somnifera (Ashwagandha)
Historical Background
Withania somnifera, commonly known as ashwagandha, belongs to the Solanaceae family and has a rich historical background in traditional medicine systems like Ayurveda. This plant has gained significant attention due to its diverse pharmacological properties, including its neuroprotective effects. Studies have highlighted the potential of Withania somnifera in protecting against neurological disorders through its bioactive components, particularly withanolide A, which has shown neuroprotective properties against hypoxia-induced and cerebral ischemia-induced apoptosis [183]. The neuroprotective effects of Withania somnifera have been demonstrated in various experimental models, such as in MPTP-intoxicated mice, where the plant extract increased dopamine content in the striatum and attenuated Parkinsonism [184].
Neuroprotective Chemical Metabolites
The wide chemical composition of Withania somnifera contributes to its neuroprotective mechanisms. Withanolides, alkaloids, steroidal lactones, and glycosides present in the plant play a crucial role in its pharmacological activities. These bioactive compounds exhibit antioxidant, anti-inflammatory, and immunomodulatory properties, which are essential for neuroprotection [185]. Withania somnifera has been reported to act as an antioxidant, protecting against lipid peroxidation and oxidative stress, thereby safeguarding erythrocytes from damage [186]. Additionally, the plant’s ability to modulate pathways like JAK-STAT and MAP kinase signaling further enhances its neuroprotective potential [187].
Clinical Applications
The neuroprotective benefits of Withania somnifera extend to clinical applications, where it has been explored as an adjunctive treatment for conditions like Parkinson’s disease. Studies have shown that Withania somnifera can improve motor symptoms in Parkinson’s patients due to its neuroprotective effects, leading to enhanced dopamine activity [188]. Furthermore, the plant has been investigated for its effects on cognitive and psychomotor performance in healthy individuals, indicating its potential to support overall brain health and function [189].
Neuroprotective Properties
Research findings have also highlighted the role of Withania somnifera in combating age-related neurodegenerative diseases. The plant’s protective role in inflammaging, a chronic low-grade inflammatory state associated with aging, has been discussed, emphasizing its potential to preserve brain health and function during the aging process. Withania somnifera’s ability to mitigate oxidative stress, enhance antioxidant activity, and modulate inflammatory pathways makes it a promising candidate for neuroprotection and overall neurological well-being [190].
General Conclusion
Withania somnifera emerges as a valuable botanical resource with significant neuroprotective effects. Its rich chemical composition, including bioactive compounds like withanolides, contributes to its diverse pharmacological properties, making it a potent agent for safeguarding against neurological disorders. From historical uses in traditional medicine to modern research validating its neuroprotective mechanisms, Withania somnifera stands out as a promising natural remedy for promoting brain health and combating neurodegenerative conditions.
3.2.5. Curcuma longa (Turmeric)
Historical Background
Curcuma longa, commonly known as turmeric, is a member of the Zingiberaceae family and is recognized for its vibrant yellow color and distinct flavor. This rhizomatous herbaceous perennial plant has a long history of traditional medicinal use and is often referred to as the “golden spice” or “Indian saffron” due to its rich cultural significance [191]. One of the key bioactive compounds found in Curcuma longa is curcumin, which has been extensively studied for its various health benefits, including its neuroprotective effects [192]. Curcumin is known for its anti-inflammatory, antioxidant, and anticancer properties, making it a promising candidate for therapeutic applications [193].
Neuroprotective Chemical Metabolites
The chemical composition of Curcuma longa, particularly its curcuminoids, has been a subject of interest in research focusing on its therapeutic potential. Curcumin, the primary bioactive compound in Curcuma longa, has been shown to possess antioxidant properties and the ability to modulate various signaling pathways involved in inflammation and cell survival. These characteristics make curcumin a valuable component of Curcuma longa with diverse pharmacological effects, including neuroprotection [191].
Neuroprotective Properties
The neuroprotective effects of Curcuma longa are attributed to its ability to modulate various molecular pathways involved in neuronal health and function. Studies have shown that curcumin can attenuate inflammation, reduce oxidative stress, and inhibit the activation of transcription factors like NF-kappa B, which play a role in neurodegenerative processes. Additionally, curcumin has been found to upregulate the expression of heme oxygenase-1 and activate AMP-activated protein kinases, which are involved in cellular stress responses and energy metabolism, further contributing to its neuroprotective effects [192].
Clinical Applications
In the context of neurological benefits, Curcuma longa has shown promise in mitigating the effects of neurodegenerative diseases such as Alzheimer’s disease. Research indicates that the active compounds in Curcuma longa, particularly curcumin, can exert neuroprotective effects through multiple mechanisms, including the modulation of apoptotic signaling pathways and the enhancement of dopaminergic synaptic function. These findings suggest that Curcuma longa may have potential therapeutic applications in the prevention and treatment of neurodegenerative disorders [194].
Clinical studies have also explored the use of Curcuma longa in various neurological conditions. For instance, research has investigated the effects of Curcuma longa in status epilepticus induced by pilocarpine in rats, demonstrating its neuroprotective properties in mitigating seizure-induced neuronal damage [195]. Furthermore, Curcuma longa has been studied for its potential role in managing conditions like arthritis, where its anti-inflammatory properties may help alleviate symptoms and improve joint function [196].
In addition to its neuroprotective effects, Curcuma longa has been investigated for its role in other health conditions, such as diabetes and cardiovascular diseases. Studies have highlighted the cardioprotective effects of Curcuma longa, including its ability to regulate serum cardiac marker enzymes and exert antioxidant, anti-inflammatory, and hypolipidemic activities [197]. Moreover, research has demonstrated the potential of Curcuma longa in managing diabetes by reducing fasting blood sugar levels and HbA1C, indicating its anti-diabetic properties [198].
General Conclusion
Overall, the research on Curcuma longa supports its neuroprotective effects through various mechanisms, including anti-inflammatory, antioxidant, and anti-apoptotic pathways. The plant’s bioactive compounds, particularly curcumin, have shown promise in mitigating neurodegenerative processes and protecting neuronal health. Studies have provided insights into the potential applications of Curcuma longa in neurological conditions, highlighting its therapeutic benefits beyond traditional medicinal uses. Further research is warranted to explore the full potential of Curcuma longa in neuroprotection and its implications for human health.
Figure 2 illustrates the mechanisms of action of various plants with neuroprotective properties. Each plant’s Latin name, major compounds, neuroprotective mechanism, and resulting neuroprotection are detailed. The figure provides an overview of how these plants exert their neuroprotective effects through specific compounds, ultimately leading to enhanced neuronal survival and function.
Table 3 presents a comprehensive overview of neuroprotective plants, detailing the utilized parts of these plants, the beneficial secondary metabolites or extract types, and the context of in vivo or in vitro studies conducted. It further highlights the effective dosages employed in these studies and the resultant outcomes observed. This synthesis of information underscores the diverse phytochemical constituents that contribute to neuroprotection, which have been shown to exert neuroprotective effects through various mechanisms. The data compiled herein may facilitate further investigation into the efficacy and safety of these natural products for clinical applications.
Table 4 presents the chemical structures of key secondary metabolites identified in various neuroprotective plants, presenting their structural diversity and highlighting their potential significance for neuroprotective properties.
4. Conclusions and Future Research Directions
In conclusion, this study on the impact of plants on the human brain has shed light on the intricate interplay between botanical species and brain health, highlighting the neuroprotective and neurotoxic potential of plants. The findings underscore the diverse mechanisms through which plant-derived compounds can influence neuronal function, oxidative stress, inflammation, and cognitive performance, offering promising avenues for neuroprotection and therapeutic intervention. Moving forward, future research directions in the field of plant-based neuroprotection and neurotoxicity should include the identification of novel neuroactive compounds, exploration of synergistic plant formulations, elucidation of molecular mechanisms of action, investigation of plant-rich diets, modulation of the gut–brain axis, targeting neuroinflammation and neuroplasticity, interaction with neurotransmitter systems, blood–brain barrier integrity, mitochondrial function, and epigenetic regulation. By advancing our understanding of the impact of plants on the human brain, researchers can harness the therapeutic potential of botanical elements to promote brain health, prevent neurological disorders, and enhance cognitive resilience.
Conceptualization, G.M., A.-R.J. and I.-A.P.; methodology, E.-A.M., A.-R.J. and I.-A.P.; software, A.-R.J., C.S.V. and R.P.; validation, C.S.V., D.C.V., A.H. and R.P.; formal analysis, D.C.V., A.H. and G.M.; investigation, A.-R.J., I.-A.P. and G.M.; resources, G.M., C.S.V., I.-A.P. and A.H.; data curation, E.-A.M., C.S.V., A.-R.J. and C.A.D.; writing—original draft preparation, A.-R.J., I.-A.P., G.M. and A.H.; writing—review and editing, E.-A.M., C.S.V., D.C.V. and R.P.; visualization, E.-A.M., A.-R.J. and C.A.D.; supervision, C.S.V., E.-A.M., C.A.D. and R.P.; project administration, G.M., A.-R.J. and C.A.D.; funding acquisition, C.A.D. and D.C.V. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
There are no additional data to be published.
The authors would like to acknowledge “Victor Babeș” University of Medicine and Pharmacy Timișoara for their support in covering the costs of publication for this research paper.
The authors declare no conflicts of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Chemical structures and structural diversity of key secondary metabolites from neurotoxic plants. The chemical structures were created using KingDrawHD v1.4.5.-20230617 software.
| Botanical Name of the Plant | Name of the Secondary Metabolites | Chemical Structures of the Metabolites | Structural Diversity |
|---|---|---|---|
| Aconitum napellus | Aconitine | [Image omitted. Please see PDF.] | Structurally, aconitine (C34H47NO11) features a bicyclic skeleton with a long aliphatic chain, a methoxy group, and a hydroxyl group. The molecular architecture contributes to its cardiotoxicity and neurotoxicity. |
| Mesaconitine | [Image omitted. Please see PDF.] | Mesaconitine (C34H47NO10) and hypaconitine (C34H47NO9) differ from aconitine through minor modifications in their functional groups and the presence of different hydroxy and methoxy groups, which impact their pharmacological profiles. | |
| Hypaconitine | [Image omitted. Please see PDF.] | ||
| Benzoylaconine | [Image omitted. Please see PDF.] | Benzoylaconine (C32H45NO10), benzoylmesaconine (C31H43NO9), and benzoylhypaconine (C31H43NO10) feature benzoyl group substitutions, which affect solubility and bioactivity. The incorporation of aromatic moieties tends to enhance their lipophilicity, potentially leading to improved cell membrane permeability. | |
| Benzoylmesaconine | [Image omitted. Please see PDF.] | ||
| Benzoylhypaconine | [Image omitted. Please see PDF.] | ||
| Atropa belladonna | Hyoscyamine | [Image omitted. Please see PDF.] | Hyoscyamine (C17H23NO3) is a naturally occurring tropane alkaloid, structurally characterized by a tropan ring fused with a cyclic ether. Its epimer, atropine (C17H23NO3), exhibits similar structural elements but differs in the spatial arrangement of its atoms, influencing its pharmacological efficacy and selectivity at muscarinic receptors. |
| Atropine | [Image omitted. Please see PDF.] | ||
| Scopolamine | [Image omitted. Please see PDF.] | Scopolamine (C17H21NO4), another tropane derivative, features an additional hydroxyl group compared to hyoscyamine, imparting distinct central nervous system effects. | |
| Conium maculatum | Coniine | [Image omitted. Please see PDF.] | Coniine (C8H17N) and γ-coniceine (C8H15N) are piperidine derivatives, with structural simplicity relative to the previously mentioned compounds. Coniine consists of a saturated piperidine ring, while γ-coniceine has a double bond, influencing their activity and toxicity. |
| γ-coniceine | [Image omitted. Please see PDF.] | ||
| Oenanthe crocata | Oenanthotoxin | [Image omitted. Please see PDF.] | Oenanthotoxin and cicutoxin are structurally complex compounds that exhibit potent neurotoxic properties. Oenanthotoxin has a tricyclic structure with multiple functional groups, while cicutoxin contains an alkaloid structure with unsaturation, highlighting the versatility of alkaloid chemistry. |
| Cicutoxin | [Image omitted. Please see PDF.] | ||
| Ricinus communis | Ricinine | [Image omitted. Please see PDF.] | Ricinine (C12H17N3O4) differs significantly from the previous alkaloids, featuring a distinct tricyclic structure with nitrogen atoms in different orientations. Its diverse functional groups suggest varied biological activities compared to the other compounds. |
Overview of neuroprotective plants: used parts, beneficial secondary metabolites/extract type, in vivo/in vitro studies and effective dosage, and outcomes.
| Plant, Family | Used Parts | Beneficial Secondary Metabolites/Extract Type | In Vivo/In Vitro Studies and Recommended | Outcomes | Refs. |
|---|---|---|---|---|---|
| Ginkgo biloba, Ginkgoaceae | Leaves | EGb 761 extract (the standardized extract of dried leaves made with acetone 60% (w/w) as the extraction solvent): 22–27% flavonoids and 5–7% terpene lactones, consisting of 2.8–3.4% A, B and C ginkgolides and 2.6–3.2% bilobalide | Randomized, placebo-controlled trials: 240 mg/day (for 12–26 weeks), 2 × 120 mg/day (for 22–24 weeks) | Neuroprotection can be achieved through several mechanisms, which include the suppression of inflammation and apoptosis, a reduction in amyloid precursor protein levels, particularly Amyloid β, and the promotion of cell proliferation within the hippocampus. At the cellular level, the neuroprotective actions encompass the elimination of free radicals, enhancement of mitochondrial performance, a decrease in blood viscosity, modulation of serotonin concentrations across different brain regions, and an elevation of dopamine levels in the prefrontal cortex. These processes collectively contribute to the preservation of neuronal health and function. | [ |
| Mice, rats: 50–100 mg/kg/day for 14 days–7 months | Antistress effects, decreasing anxiety level and MAO activity. | [ | |||
| Mice: 10 mg/kg/day (i.p.) for 17 days | Reduction in lipid peroxidation and superoxide radical production, and modulation of serotonergic and dopaminergic neurotransmission → antidepressant-like effect. | [ | |||
| Randomized, placebo-controlled clinical trials evaluating efficacy in dementia: 120 mg/day (52–26 weeks), 240 mg/day (12–24 weeks) | Significant improvement in cognitive function. | [ | |||
| Rats: 4 mg/kg BW (for 8 weeks) | The extract promotes the secretion of estrogen-dependent biogenic amines within the hippocampus. Additionally, it mitigates neuronal damage in the hippocampus through its antioxidant properties and its ability to stimulate adiponectin release. Furthermore, it has the potential to manage memory and learning impairments effectively. | [ | |||
| Healthy volunteers (18–26 years): 120, 240, 360 mg/day—single doses; 120 mg/day for 6 weeks | Improved cognitive performance, self-esteem, and mood, increasing attention efficiency and improving memory quality. | [ | |||
| Patients with mild to moderate dementia, Alzheimer’s disease (50–70 years): 240 mg/day for 24 weeks | Overall improvement in cognitive functions and general condition. | [ | |||
| Centella asiatica, Apiaceae | The aerial parts (leaves and stems) | 70% hydro-ethanolic extract | Clinical study (patients 18–60 years old): 500 mg/capsule, twice daily for 60 days | Overall improvement in stress, anxiety, depression, adjustment, and attention. | [ |
| Ethanolic extract | Rats: 200, 300 mg/kg BW/day (p.o.) for 21 days | Improved neurobehavioral activity and reduced tissue death due to lack of oxygen. Additionally, there was considerable safeguarding against neuronal damage, as indicated by the preservation of hippocampal and cortical neurons. | [ | ||
| Aqueous leaf extract | Rats: 500 mg/kg BW (p.o.) | The extract reduced behavioral impairments and enhanced learning and memory performance. | [ | ||
| ECa233 (standardized extract): 85% triterpenoid glycoside, divided into madecassoside (53.1%) and asiaticoside (32.3%) in a ratio of 1.5:0.5; 15% triterpenoid saponins, of which less than 1% are triterpenic acid metabolites (madecassic acid and asiatic acid) | Rats: 30 mg/kg (p.o.) | Significantly enhanced memory retention, with an increase in synaptic-related proteins in the hippocampus, leading to a strong synaptic plasticity enhancement. It also demonstrated an anxiolytic effect. | [ | ||
| In vitro (neuroblastoma cell lines): 100 μg/mL | Significant stimulatory effects on the elongation of neuroblastoma cell neurites. | [ | |||
| Extract containing tannic acid (29.9 mg/g), asiaticoside (1.09 mg/g), and asiatic acid (48.89 mg/g) | Randomized, double-blind, placebo-controlled clinical study (mean age: 65 years): 250, 500, 750 mg/day for 2 months | Enhanced overall cognitive functions, memory, and self-rated mood. | [ | ||
| Clinical study (mean age: 65 years): 1000 mg/day for 6 months | Significant cognitive improvement. | ||||
| Capsules of 70% hydro-ethanolic extract of dried aerial parts | Open-label (adults with generalized anxiety disorder, mean age 33 years): 500 mg twice daily for 2 months | The capsules demonstrated a multifaceted impact on psychological well-being, as they significantly lowered anxiety levels, increased self-perceived stress, decreased the depression index, enhanced the adjustment index, and elevated attention levels. | [ | ||
| Panax ginseng, Araliaceae | Roots | Panax ginseng extract: ginsenosides (the main, 70–80%, found in fresh ginseng are Rb2, Rb1, Re, Rg1, Rc) | Rats: 100 mg/kg (p.o.) for 2 weeks | Enhanced alterations in the midbrain and striatum, as well as demonstrated a partial therapeutic effect in a rat model of Parkinson’s disease. | [ |
| Total saponins | Mice: 50, 100, 200 mg/kg/day (p.o.) | Memory deterioration was mitigated through the enhancement of antioxidant levels in the hippocampus, alongside an increase in proteins associated with neural plasticity. | [ | ||
| Glycoprotein PGL-1 | Rats: 40, 80, 160 mg/kg·d−1 (i.p.) for 35 days | The treatment significantly improved the learning and memory abilities in the Alzheimer’s disease rat model. The neuroprotective effects of PGL-1 may be associated with its ability to suppress nitric oxide synthesis. | [ | ||
| Ginsenoside Rg1 | Mice: 10 mg/kg (i.p.) for 14 days | Ginsenoside Rg1 has demonstrated the ability to inhibit the activation of microglial cells triggered by lipopolysaccharides and to safeguard dopaminergic neurons within the nigrostriatal pathway. This suggests that Rg1 could serve as a potential therapeutic approach to mitigate inflammatory harm associated with chronic neurodegenerative disorders. | [ | ||
| Korean red ginseng (KRG) | Rats: 20, 50, 100 mg/kg (i.p.) for 14 days | The administration of KRG has been shown to enhance cognitive functions and capabilities, including the processes of learning acquisition, memory consolidation, and the reduction in fear memory in the animal model exhibiting memory impairment due to SPS. These results indicate that KRG may serve as a beneficial alternative therapy for cognitive dysfunctions associated with traumatic stress, particularly in conditions like PTSD. | [ | ||
| Withania somnifera, Solanaceae | Roots, leaves (occasionally) | A standardized extract: 2.6% withanolides including withanolides IV (0.87%) and V (0.65%), withaferin A (0.56%), withanolide A (0.20%) and B (0.06%), and 12-deoxy withastramonolide (0.26%) | In vitro (human neuroblastoma cell line): 12–50 µg/mL | The extract demonstrated neuroprotective activities through multiple mechanisms, including protection against Aβ and acrolein toxicity, reduction in oxidative stress, and inhibition of AChE activity. | [ |
| Withanone extracted from the roots | Rats: 5, 10, 20 mg/kg (p.o.) for 21 days | Withanone exhibits a significant protective effect against amyloid β toxicity, which is crucial in the context of neurodegenerative diseases such as Alzheimer’s. Withanone not only enhances memory retention but also significantly mitigates cognitive impairment associated with Aβ accumulation. Furthermore, the compound effectively attenuates elevated levels of pro-inflammatory cytokines, suggesting a dual mechanism of action that involves both neuroprotection and anti-inflammatory effects. | [ | ||
| Ethanolic extract | Rats: 200 mg/kg (p.o.) for 30 days | The extract exhibits properties that combat neurotoxicity through its antioxidant and anti-inflammatory actions, effectively mitigating oxidative stress, neuroinflammation, and excitotoxicity. Furthermore, it may help preserve cholinergic function by regulating acetylcholinesterase activity, suggesting its potential role as a cognitive enhancer. Consequently, ashwagandha extract could be considered a complementary treatment option for Alzheimer’s disease. | [ | ||
| Hydro-ethanolic extract from roots | Rats: 500 mg/mL (p.o.) for 6 weeks | The extract may safeguard against memory deficits associated with PTSD, both in the short and long term, potentially by counteracting oxidative stress in the hippocampus. | [ | ||
| Standardized ethanolic extract: 11.90% withanolide glycosides, 1.05% withaferin A, 40.25% oligosaccharides, 0.05% alkaloids, 3.44% polysaccharides. | Double-blind, randomized, | The administration of ashwagandha was associated with a decrease in subjective experiences of stress and anxiety in chronically stressed adults. Furthermore, it has been shown to lower serum levels of cortisol and C-reactive protein, as well as reduce pulse rate and blood pressure. Additionally, ashwagandha supplementation contributes to improvements in fasting blood glucose levels and lipid profiles. These findings suggest that ashwagandha may play a beneficial role in managing physiological and psychological stress responses, alongside enhancing metabolic health indicators. | [ | ||
| Curcuma longa, Zingiberaceae | Rhizome | Curcumin | Rats: divided into two different groups: | Alcohol treatment in the rats resulted in significant increases in cholesterol, phospholipids, free fatty acids, and TBARS levels in the brain compared to the control group, which received no alcohol at all. It was shown that administration of the alcoholic extract with curcumin led to a considerable decrease in cholesterol, phospholipids, and TBARS levels, and glutathione levels were partially restored. This supports the fact that curcumin has a protective effect on the brain, reducing oxidative stress and alleviating alcohol damage. | [ |
| Alcoholic extract dissolved in Tween 20 before administration | Mice: 100 mg/kg (p.o.) for 13 weeks | Curcumin administration was effective in significantly improving memory, demonstrating once again its neuroprotective effect. | [ | ||
| Curcumin | In vitro (rat adrenal pheochromocytoma PC12 cells): 0, 25, 50, 100, 150 and 200 μM for 24 h | In vitro treatment with curcumin has been shown to significantly reduce cellular damage and decrease 6-OHDA-induced mortality. | [ | ||
| Aqueous extract | Rats: 100 mg/kg BW/day | Results of the in vivo study showed that Curcuma longa extract helped to improve learning ability in elderly rats, having a neuroprotective effect against cognitive impairment associated with aging or Alzheimer’s disease. | [ |
p.o. = per os; s.c. = subcutaneously; i.p. = intraperitoneally; i.v. = intravenously.
Chemical structures and structural diversity of key secondary metabolites from neuroprotective plants. The chemical structures were created using KingDrawHD v1.4.5.-20230617 software.
| Botanical Name of the Plant | Name of the Secondary Metabolites | Chemical Structures of the Metabolites | Structural Diversity |
|---|---|---|---|
| Ginkgo biloba | Flavonoids (kaempferol, quercetin, isorhamnetin derivatives). | [Image omitted. Please see PDF.] | Flavonoids are polyphenolic compounds characterized by a flavone backbone, featuring various substitutions that alter their chemical properties and biological activities. Kaempferol has multiple hydroxyl groups that can donate hydrogen and provide antioxidant properties. Quercetin possesses a similar structure but has an additional double bond and ketone, enhancing its bioactivity and solubility. Isorhamnetin is a methoxy derivative of quercetin that exhibits different pharmacokinetics and increased lipid solubility. |
| [Image omitted. Please see PDF.] | |||
| [Image omitted. Please see PDF.] | |||
| Terpene lactones: ginkgolides (A, B, C, J, M) and bilobalide | [Image omitted. Please see PDF.] | Ginkgolides are a class of diterpene lactones found in Ginkgo biloba, exhibiting significant pharmacological properties. The major ginkgolides—A, B, C, J, and M—possess distinct structural features, including two terpene units and various functional groups that diversify their activity. Ginkgolide A and B are characterized by their unique bicyclic structures, impacting their receptor binding interactions. Bilobalide, another key compound, is a sesquiterpene derivative that complements the activity of ginkgolides. | |
| Centella asiatica | Triterpenoid glycoside: madecassoside, asiaticoside | [Image omitted. Please see PDF.] | Triterpenoid glycosides, such as madecassoside and asiaticoside, display a complex structure consisting of a triterpene backbone linked to sugar moieties. This glycosylation affects their solubility and bioavailability. Madecassoside exhibits a pentacyclic triterpene structure with various sugar attachments, increasing its medicinal properties. Asiaticoside, a closely related compound, differs from its sugar moieties, which contributes to its distinct pharmacological profile. |
| Panax ginseng | Ginsenosides (Rg1, Re, Rb1, Rc, Rd) | [Image omitted. Please see PDF.] | Ginsenosides encompass a diverse range of triterpenoid saponins, including Rg1, Re, Rb1, Rc, and Rd. Each ginsenoside exhibits variability in sugar chains and structure, influencing its pharmacological properties. Rg1 has a protopanaxadiol framework that promotes nerve cell regeneration. Re and Rb1 contain additional sugar moieties that enhance their bioavailability and activity in modulating immune responses. |
| Withania somnifera | Withanolide A | [Image omitted. Please see PDF.] | Withanolides, derived from Withania somnifera, encompass a diverse group of steroidal lactones. Important representatives, including withanolide A, B, withanone, and withaferin A, exhibit variations in side chains and functional groups. Withanolide A features a complex cyclic structure with multiple hydroxyl substitutions, enhancing its bioactivity. Withaferin A has a highly oxygenated ring structure that contributes to its potent cytotoxicity against cancer cells. |
| Withanolide B | [Image omitted. Please see PDF.] | ||
| Withanone | [Image omitted. Please see PDF.] | ||
| Withaferin A | [Image omitted. Please see PDF.] | ||
| Withanoside IV | [Image omitted. Please see PDF.] | ||
| Withanoside V | [Image omitted. Please see PDF.] | ||
| Curcuma longa | Curcumin | [Image omitted. Please see PDF.] | Curcumin (C21H20O6) features a unique structure characterized by two feruloyl moieties connected by a methylene bridge. This structure is pivotal to curcumin’s interaction with biological targets. |
| Demethoxycurcumin | [Image omitted. Please see PDF.] | Demethoxycurcumin (C20H18O5) is a derivative where one of the methoxy groups from curcumin is removed. This structural alteration has been shown to affect its binding affinity to various biological targets and its resultant therapeutic potential. | |
| Bisdemethoxycurcumin | [Image omitted. Please see PDF.] | Bisdemethoxycurcumin (C19H16O4) has both methoxy groups removed from the parent curcumin structure. This compound exhibits altered biological activities, showcasing how subtle changes in structure can lead to significant variations in pharmacodynamics. |
References
1. Moreira, J.; Machado, M.; Dias-Teixeira, M.; Ferraz, R.; Delerue-Matos, C.; Grosso, C. The neuroprotective effect of traditional Chinese medicinal plants—A critical review. Acta Pharm. Sin. B; 2023; 13, pp. 3208-3237. [DOI: https://dx.doi.org/10.1016/j.apsb.2023.06.009] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37655317]
2. Rehman, M.; Wali, A.; Ahmad, A.; Shakeel, S.; Rasool, S.; Ali, R.; Rashid, S.M.; Madkhali, H.; Ganaie, M.A.; Khan, R. Neuroprotective strategies for neurological disorders by natural products: An update. Curr. Neuropharmacol.; 2019; 17, pp. 247-267. [DOI: https://dx.doi.org/10.2174/1570159X16666180911124605] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30207234]
3. Wojtunik-Kulesza, K. Toxicity of selected monoterpenes and essential oils rich in these compounds. Molecules; 2022; 27, 1716. [DOI: https://dx.doi.org/10.3390/molecules27051716] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35268817]
4. Kim, J.; Lyu, Y.; Lee, M.; Kang, H. Neuroprotective effect of some plant extracts in cultured CT105-induced PC12 cells. Biol. Pharm. Bull.; 2006; 29, pp. 2021-2024. [DOI: https://dx.doi.org/10.1248/bpb.29.2021]
5. Vauzour, D. Dietary polyphenols as modulators of brain functions: Biological actions and molecular mechanisms underpinning their beneficial effects. Oxidative Med. Cell. Longev.; 2012; 2012, 914273. [DOI: https://dx.doi.org/10.1155/2012/914273]
6. Nadège, K.; Sylviane, D.; Agathe, F.; Clarisse, M.; Germain, T.; David, P.; Simon, P.; Stephanie, M.; Elisabeth, N. Antioxidant properties of Dichrocephala integrifolia (Asteraceae) in a mouse model of monosodium glutamate-induced neurotoxicity. Afr. J. Tradit. Complement. Altern. Med.; 2017; 14, pp. 147-155. [DOI: https://dx.doi.org/10.21010/ajtcam.v14i5.18]
7. Lahane, V.D.; Katekar, L. Exploring the neuroprotective potential of herbal plants: A comprehensive review. GSC Biol. Pharm. Sci.; 2024; 27, pp. 141-148. [DOI: https://dx.doi.org/10.30574/gscbps.2024.27.3.0175]
8. Oliveira, A.; Pinho, C.; Sarmento, B.; Dias, A. Neuroprotective activity of Hypericum perforatum and its major components. Front. Plant Sci.; 2016; 7, 1004. [DOI: https://dx.doi.org/10.3389/fpls.2016.01004]
9. Khalil, H.; Henafy, H.; Khalil, I.; Bakr, A.; Fahmy, M.; Younis, N.; El-Shiekh, R. Hypericum perforatum L. Nanoemulsion Mitigates Cisplatin-Induced Chemobrain via Reducing Neurobehavioral Alterations, Oxidative Stress, Neuroinflammation, and Apoptosis in Adult Rats. Toxics; 2023; 11, 159. [DOI: https://dx.doi.org/10.3390/toxics11020159]
10. Pereira, R.; Fachinetto, R.; Prestes, A.; Puntel, R.; Silva, G.; Heinzmann, B.; Boschetti, T.; Athayde, M.; Burger, M.; Morel, A. et al. Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita, and Cymbopogon citratus. Neurochem. Res.; 2008; 34, pp. 973-983. [DOI: https://dx.doi.org/10.1007/s11064-008-9861-z]
11. Kumar, G.; Raghavan, A.; Naveen, S. Phytochemicals having neuroprotective properties from dietary sources and medicinal herbs. Pharmacogn. J.; 2014; 7, pp. 1-17. [DOI: https://dx.doi.org/10.5530/pj.2015.1.1]
12. Turkez, H.; Arslan, M.; Stefano, A.; Cacciatore, I.; Mardinoglu, A. Nonpharmacological treatment options for Alzheimer’s disease: From animal testing to clinical studies. Turk. J. Zool.; 2020; 44, pp. 81-89. [DOI: https://dx.doi.org/10.3906/zoo-1911-32]
13. Popescu, R.; Daliborca, C.V.; Cimporescu, A.; Vlad, C.S.; Verdes, D.; Botau, D.; Filimon, M.; Pauliuc, I.; Citu, C.; Dumitrascu, V. Chemical Properties and In vitro Antitumor Effects of Momordica charantia Extracts in Different Solvents. Rev. Chim.; 2016; 67, pp. 69-73.
14. Mioc, M.; Prodea, A.; Racoviceanu, R.; Mioc, A.; Ghiulai, R.; Milan, A.; Voicu, M.; Mardale, G.; Soica, C. Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part II). Int. J. Mol. Sci.; 2022; 23, 8896. [DOI: https://dx.doi.org/10.3390/ijms23168896]
15. Dereli-Caliskan, N.; Husunet, M.; Ila, H.; Karagoz, I. Determination of potential anti-Alzheimer activity of gentiopicroside and isoorientin using molecular docking studies. Eurasia Proc. Sci. Technol. Eng. Math.; 2021; 12, pp. 106-112. [DOI: https://dx.doi.org/10.55549/epstem.1038383]
16. Daliborca, C.V.; Dumitrascu, V.; Popescu, R.; Cimporescu, A.; Vlad, C.S.; Flangea, C.; Grecu, D.S.; Vagvolgyi, C.; Papp, T.; Horhat, F. Gas Chromatography–mass Spectrometry Evidences for New Chemical Insights of Momordica charantia. Rev. Chim.; 2015; 66, pp. 1914-1920.
17. Codocedo, J.; Allard, C.; Godoy, J.; Varela-Nallar, L.; Inestrosa, N. SIRT1 regulates dendritic development in hippocampal neurons. PLoS ONE; 2012; 7, e47073. [DOI: https://dx.doi.org/10.1371/journal.pone.0047073]
18. Sakarwal, A.; Sen, K.; Ram, H.; Chowdhury, S.; Kashyap, P.; Shukla, S.; Panwar, A. Neuroprotective Efficacy of Phytoconstituents of Methanolic Shoots Extract of Calligonum polygonoides L. in Hypercholesterolemia-associated Neurodegenerations. Endocr. Metab. Immune Disord.-Drug Targets; 2024; 24, e020424228551. [DOI: https://dx.doi.org/10.2174/0118715303283666240319062925]
19. Lucena, G.; Franco, J.; Ribas, C.; Azevedo, M.; Meotti, F.; Gadotti, V.; Dafre, A.; Santos, A.; Farina, M. Cipura Paludosa extract prevents methyl mercury-induced neurotoxicity in mice. Basic Clin. Pharmacol. Toxicol.; 2007; 101, pp. 27-131. [DOI: https://dx.doi.org/10.1111/j.1742-7843.2007.00091.x]
20. Ye, C.; Wu, Y.; Shen, S.; Liu, X.; Guo, J. A structure-activity relationship between the Veratrum alkaloids on the antihypertension and DNA damage activity in mice. Chem. Biodivers.; 2020; 17, e1900473. [DOI: https://dx.doi.org/10.1002/cbdv.201900473]
21. Gao, X.; Hu, J.; Zhang, X.; Zuo, Y.; Wang, Y.; Zhu, S. Research progress of aconitine toxicity and forensic analysis of aconitine poisoning. Forensic Sci. Res.; 2018; 5, pp. 25-31. [DOI: https://dx.doi.org/10.1080/20961790.2018.1452346] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32490307]
22. Manna, P.; Mohanta, G.; Valliappan, K.; Manavalan, R. Lathyrus and lathyrism: A review. Int. J. Food Prop.; 1999; 2, pp. 197-203. [DOI: https://dx.doi.org/10.1080/10942919909524604]
23. Rao, S.; Adiga, P.; Sarma, P. The isolation and characterization of β-n-oxalyl-l-α,β-diaminopropionic acid: A neurotoxin from the seeds of Lathyrus sativus. Biochemistry; 1964; 3, pp. 432-436. [DOI: https://dx.doi.org/10.1021/bi00891a022]
24. Wei, X.; Ruan, W.; Vrieling, K. Current knowledge and perspectives of pyrrolizidine alkaloids in pharmacological applications: A mini-review. Molecules; 2021; 26, 1970. [DOI: https://dx.doi.org/10.3390/molecules26071970]
25. Chen, H.; Wang, F.; Ni, X.; Rigui, Y.; Bai, Y.; Xu, L.; Yang, J.; Zhang, X.; Deng, J.; Li, J. et al. Aconitine disrupts serotonin neurotransmission via 5-hydroxytryptamine receptor in zebrafish embryo. J. Appl. Toxicol.; 2020; 41, pp. 483-492. [DOI: https://dx.doi.org/10.1002/jat.4059]
26. Spencer, P.; Palmer, V. Direct and indirect neurotoxic potential of metal/metalloids in plants and fungi used for food, dietary supplements, and herbal medicine. Toxics; 2021; 9, 57. [DOI: https://dx.doi.org/10.3390/toxics9030057]
27. Nissim, I.; Dagan-Wiener, A.; Niv, M. The taste of toxicity: A quantitative analysis of bitter and toxic molecules. IUBMB Life; 2017; 69, pp. 938-946. [DOI: https://dx.doi.org/10.1002/iub.1694]
28. Grandjean, P. Paracelsus revisited: The dose concept in a complex world. Basic Clin. Pharmacol. Toxicol.; 2016; 119, pp. 126-132. [DOI: https://dx.doi.org/10.1111/bcpt.12622]
29. Elyasi, L.; Rosenholm, J.; Jamshidi, F.; Jahanshahi, M. The antioxidative effects of picein and its neuroprotective potential: A review of the literature. Molecules; 2022; 27, 6189. [DOI: https://dx.doi.org/10.3390/molecules27196189]
30. Bauer, N. Unraveling the interplay of dopamine, carbon monoxide, and heme oxygenase in neuromodulation and cognition. ACS Chem. Neurosci.; 2024; 15, pp. 400-407. [DOI: https://dx.doi.org/10.1021/acschemneuro.3c00742]
31. Calabrese, E. The emergence of the dose-response concept in biology and medicine. Int. J. Mol. Sci.; 2016; 17, 2034. [DOI: https://dx.doi.org/10.3390/ijms17122034] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27929392]
32. Nourbakhsh, F.; Tajbakhsh, E. Neurotoxicity mechanism of Ochratoxin A. Qual. Assur. Saf. Crops Foods; 2021; 13, pp. 34-45. [DOI: https://dx.doi.org/10.15586/qas.v13i2.837]
33. Fang, C. Network pharmacology study on the neurotoxic mechanism of Acorus tatarinowii. Adv. Eng. Technol. Res.; 2023; 7, 647. [DOI: https://dx.doi.org/10.56028/aetr.7.1.647.2023]
34. Gaitonde, B.; Joglekar, S. Mechanism of neurotoxicity of cardiotonic glycosides. Br. J. Pharmacol.; 1977; 59, pp. 223-229. [DOI: https://dx.doi.org/10.1111/j.1476-5381.1977.tb07482.x]
35. Tichvon, C. Synthesis of bufadienolide cinobufagin via late-stage singlet oxygen oxidation/rearrangement approach. Org. Lett.; 2024; 26, pp. 2445-2450. [DOI: https://dx.doi.org/10.1021/acs.orglett.4c00625]
36. Spochacz, M.; Chowański, S.; Walkowiak-Nowicka, K.; Szymczak, M.; Adamski, Z. Plant-derived substances used against beetles–pests of stored crops and food–and their mode of action: A review. Compr. Rev. Food Sci. Food Saf.; 2018; 17, pp. 1339-1366. [DOI: https://dx.doi.org/10.1111/1541-4337.12377]
37. Xu, X.; Jia, L.; Ma, X.; Li, H.; Sun, C. Application potential of plant-derived medicines in prevention and treatment of platinum-induced peripheral neurotoxicity. Front. Pharmacol.; 2022; 12, 792331. [DOI: https://dx.doi.org/10.3389/fphar.2021.792331]
38. Kausar, S.; Wang, F.; Cui, H. The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells; 2018; 7, 274. [DOI: https://dx.doi.org/10.3390/cells7120274]
39. Zhao, Y. Phthalates induce neurotoxicity by disrupting the MFN2-PERK axis-mediated endoplasmic reticulum–mitochondria interaction. J. Agric. Food Chem.; 2024; 72, pp. 7411-7422. [DOI: https://dx.doi.org/10.1021/acs.jafc.3c07752]
40. Guo, W.; Xing, Y.; Luo, X.; Li, F.; Ren, M.; Liang, Y. Reactive Oxygen Species: A Crosslink between Plant and Human Eukaryotic Cell Systems. Int. J. Mol. Sci.; 2023; 24, 13052. [DOI: https://dx.doi.org/10.3390/ijms241713052]
41. Povšnar, M.; Koželj, G.; Kreft, S.; Lumpert, M. Rare tradition of the folk medicinal use of Aconitum spp. is kept alive in Solčavsko, Slovenia. J. Ethnobiol. Ethnomed.; 2017; 13, 45. [DOI: https://dx.doi.org/10.1186/s13002-017-0171-x] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28789666]
42. Shyaula, S. Phytochemicals, traditional uses and processing of Aconitum species in Nepal. Nepal J. Sci. Technol.; 2012; 12, pp. 171-178. [DOI: https://dx.doi.org/10.3126/njst.v12i0.6496]
43. Li, L.; Zhang, L.; Liao, T.; Zhang, C.; Chen, K.; Huang, Q. Advances on pharmacology and toxicology of aconitine. Fundam. Clin. Pharmacol.; 2022; 36, pp. 601-611. [DOI: https://dx.doi.org/10.1111/fcp.12761] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35060168]
44. Eric, N.; Xu, Y.; Li, Y.; Wang, Y.; Agyemang, K.; Zhang, Y. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J. Pharm. Pharmacol.; 2014; 67, pp. 1-19. [DOI: https://dx.doi.org/10.1111/jphp.12310]
45. Chou, P.; Wang, C.; Tai, C.; Yang, T.; Tang, Y. Bradycardia and hypotension from improper use of aconite root: A case report and brief review. Complement. Med. Res.; 2018; 25, pp. 338-343. [DOI: https://dx.doi.org/10.1159/000489179]
46. Chan, T. Aconite poisoning presenting as hypotension and bradycardia. Hum. Exp. Toxicol.; 2009; 28, pp. 795-797. [DOI: https://dx.doi.org/10.1177/0960327109353056]
47. Feng, C.; Li, H.; Liu, M. Clinical effect of a temporary pacemaker on an electrical storm induced by severe acute aconitine poisoning. World Acad. Sci. J.; 2022; 4, 142. [DOI: https://dx.doi.org/10.3892/wasj.2022.142]
48. Lee, J.; Choi, J.; Park, H.; Yoon, C.; Park, S.; Baek, S.; Cho, S. Development and validation of q-tof/ms method for the rapid and simultaneous quantification of three aconitum alkaloids in food. Anal. Methods; 2015; 7, pp. 7733-7740. [DOI: https://dx.doi.org/10.1039/C5AY01316J]
49. Zhang, Y.; Shu, Z.; Yin, L.; Ma, L.; Wang, X.; Fu, X. Anti-inflammatory and antinociceptive activities of non-alkaloids fractions from Aconitum flavum in vivo. Rev. Bras. Farmacogn.; 2015; 25, pp. 47-52. [DOI: https://dx.doi.org/10.1016/j.bjp.2014.11.013]
50. Bonanno, G.; Ippolito, M.; Moscarelli, A.; Misseri, G.; Caradonna, R.; Accurso, G.; Cortegiani, A.; Giarratano, A. Accidental poisoning with Aconitum: Case report and review of the literature. Clin. Case Rep.; 2020; 8, pp. 696-698. [DOI: https://dx.doi.org/10.1002/ccr3.2699]
51. Chan, Y.; Wang, N.; Feng, Y. The toxicology and detoxification of Aconitum: Traditional and modern views. Chin. Med.; 2021; 16, 61. [DOI: https://dx.doi.org/10.1186/s13020-021-00472-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34315520]
52. He, H.; Fang, Y. Relative quantification of the metabolite of aconitine in rat urine by LC-ESI-MS/MS and its application to pharmacokinetics. Anal. Sci.; 2012; 28, pp. 1203-1205. [DOI: https://dx.doi.org/10.2116/analsci.28.1203] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23232242]
53. Yin, Y.; Liu, J.; Xu, H.; Du, Y.; Li, Q.; Bi, K. Simultaneous determination of benzoylmesaconine and piperine in rat plasma after oral administration of naru-3 by an ultra fast liquid chromatography-tandem mass spectrometry method and its application in a comparative pharmacokinetic study. Anal. Methods; 2014; 6, pp. 3420-3428. [DOI: https://dx.doi.org/10.1039/C3AY42077A]
54. Li, T.; Gong, N.; Wang, Y. Ester hydrolysis differentially reduces aconitine-induced anti-hypersensitivity and acute neurotoxicity: Involvement of spinal microglial dynorphin expression and implications for Aconitum processing. Front. Pharmacol.; 2016; 7, 367. [DOI: https://dx.doi.org/10.3389/fphar.2016.00367] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27761113]
55. Fu, P.; Zhang, N.; Wang, C.; Wang, X.; Huang, W.; Peng, C.; He, G.; Han, B. Aconitine induces cardiomyocyte damage by mitigating BNIP3-dependent mitophagy and the TNFA-NLRP3 signaling axis. Cell Prolif.; 2019; 53, e12701. [DOI: https://dx.doi.org/10.1111/cpr.12701]
56. Chen, X.; Guo, H.; Li, Q.; Liu, H.; Zhang, X.; Xie, K.; Zhu, Z.; Miao, Q.; Su, S. Protective effect of berberine on Aconite-induced myocardial injury and the associated mechanisms. Mol. Med. Rep.; 2018; 18, pp. 4468-4476. [DOI: https://dx.doi.org/10.3892/mmr.2018.9476]
57. Ameri, A. The effects of Aconitum alkaloids on the central nervous system. Prog. Neurobiol.; 1998; 56, pp. 211-235. [DOI: https://dx.doi.org/10.1016/S0301-0082(98)00037-9]
58. Wu, J.; Lin, N.; Li, F.; Zhang, G.; He, S.; Zhu, Y.; Ou, R.; Li, N.; Liu, S.; Feng, L. et al. Induction of P-glycoprotein expression and activity by Aconitum alkaloids: Implication for clinical drug–drug interactions. Sci. Rep.; 2016; 6, 25343. [DOI: https://dx.doi.org/10.1038/srep25343]
59. Sheikh-Zade, Y.R.; Cherednik, I.L.; Galenko-Yaroshevskii, P.A. Peculiarities of cardiotropic effect of aconitine. Bull. Exp. Biol. Med.; 2000; 129, pp. 365-366. [DOI: https://dx.doi.org/10.1007/BF02439272]
60. Lin, X.; Zhang, J.; Wu, Z.; Shi, Y.; Chen, M.; Li, M.; Hu, H.; Tian, K.; Lv, X.; Li, C. et al. Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling. Front. Pharmacol.; 2024; 15, 1393717. [DOI: https://dx.doi.org/10.3389/fphar.2024.1393717]
61. Wangchuk, P.; Navarro, S.; Shepherd, C.; Keller, P.; Pyne, S.; Loukas, A. Diterpenoid alkaloids of Aconitum laciniatum and mitigation of inflammation by 14-O- acetylneoline in a murine model of ulcerative colitis. Sci. Rep.; 2015; 5, 12845. [DOI: https://dx.doi.org/10.1038/srep12845] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26240038]
62. Maurya, S.; Seth, A.; Laloo, D.; Singh, N.; Gautam, D.; Singh, A. Śodhana: An ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants. Anc. Sci. Life; 2015; 34, pp. 188-197. [DOI: https://dx.doi.org/10.4103/0257-7941.160862]
63. Rabb, U. Pharmacological review on purification of visha dravyas (poisonous plants) according to Ayurveda. Int. J. Curr. Sci. Res. Rev.; 2022; 5, pp. 3265-3272. [DOI: https://dx.doi.org/10.47191/ijcsrr/V5-i8-58]
64. Pal, P.; Nandi, M.; Singh, N. Detoxification of Croton tiglium L. seeds by ayurvedic process of śodhana. Anc. Sci. Life; 2014; 33, pp. 157-161. [DOI: https://dx.doi.org/10.4103/0257-7941.144619]
65. Arya, N.; Kumar, H. Comparative physico-chemical profile of ‘vatsanabha’ (Aconitum ferox, Ranunculaceae) mula processed through cow’s urine and cow’s milk. Int. J. Res. Ayurveda Pharm.; 2017; 8, pp. 217-222. [DOI: https://dx.doi.org/10.7897/2277-4343.085278]
66. Mitra, S.; Shukla, V.; Acharya, R. Effect of shodhana (processing) on kupeelu (Strychnos nux-vomica Linn.) with special reference to strychnine and brucine content. AYU Int. Q. J. Res. Ayurveda; 2011; 32, pp. 402-407. [DOI: https://dx.doi.org/10.4103/0974-8520.93923]
67. Deore, S.; Moon, K.; Khadabadi, S.; Deokate, U.; Baviskar, B. Evaluation of toxicity of ‘vatsanabha’ (Aconitum ferox, Ranunculaceae) before and after shodhana. J. Young Pharm.; 2013; 5, pp. 3-6. [DOI: https://dx.doi.org/10.1016/j.jyp.2013.01.001]
68. Vyas, K.; Shukla, V.; Ruknuddin, G.; Prajapati, P. Pharmaceutical standardization of guggulu śodhana. J. Ayurveda Med. Sci.; 2017; 2, pp. 165-173. [DOI: https://dx.doi.org/10.5530/jams.2017.2.12]
69. Li, H.; Liu, L.; Zhu, S.; Liu, Q. Case reports of Aconite poisoning in mainland China from 2004 to 2015: A retrospective analysis. J. Forensic Leg. Med.; 2016; 42, pp. 68-73. [DOI: https://dx.doi.org/10.1016/j.jflm.2016.05.016]
70. Chan, T.Y. Aconite poisoning. Clin. Toxicol.; 2009; 47, pp. 279-285. [DOI: https://dx.doi.org/10.1080/15563650902904407]
71. Danaie, E.; Masoudi, S.; Masnabadi, N. Chemical composition analysis of Atropa belladonna Grown in Iran and Evaluation of Antibacterial properties of Extract-loaded Nanofibers. Iran. J. Pharm. Res.; 2023; 22, e137839. [DOI: https://dx.doi.org/10.5812/ijpr-137839] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/38148889]
72. Rajput, H. Effects of Atropa belladonna as an anti-cholinergic. Nat. Prod. Chem. Res.; 2014; 1, 1000104. [DOI: https://dx.doi.org/10.4172/2329-6836.1000104]
73. Hasgül, B.; Çatak, M.; Çatak, A.; Karaman, S. Case series with Atropa belladonna (deadly nightshade) intoxication and experience of physostigmin. J. Emerg. Med. Case Rep.; 2022; 13, pp. 25-28. [DOI: https://dx.doi.org/10.33706/jemcr.998002]
74. Schoen-Angerer, T.; Madeleyn, R.; Kiene, H.; Kienle, G.; Vagedes, J. Improvement of asthma and gastroesophageal reflux disease with oral pulvis stomachicus cum belladonna, a combination of Matricaria recutita, Atropa belladonna, bismuth, and antimonite: A pediatric case report. Glob. Adv. Health Med.; 2016; 5, pp. 107-111. [DOI: https://dx.doi.org/10.7453/gahmj.2015.019]
75. Bektaş, M.; Aktar, F.; Güneş, A.; Uluca, Ü.; Gülşen, S.; Karaman, K. Atropa belladonna (deadly nightshade) poisoning in chilhood. West Indian Med. J.; 2016; 69, pp. 230-234. [DOI: https://dx.doi.org/10.7727/wimj.2015.457]
76. Maurya, V.; Kumar, S.; Kabir, R.; Shrivastava, G.; Shanker, K.; Nayak, D.; Khurana, A.; Manchanda, R.; Gadugu, S.; Kar, S. et al. Dark classics in chemical neuroscience: An evidence-based systematic review of belladonna. ACS Chem. Neurosci.; 2020; 11, pp. 3937-3954. [DOI: https://dx.doi.org/10.1021/acschemneuro.0c00413]
77. Ashtiania, F. Tropane alkaloids of Atropa belladonna L. and Atropa acuminata Royle ex Miers plants. J. Med. Plants Res.; 2011; 5, pp. 6515-6522. [DOI: https://dx.doi.org/10.5897/jmpr11.482]
78. Yılmaz, Y.; Kara, F.; Aydın, S.; Ozlece, H.; Can, S.; Üstebay, S. Poisoning with Atropa belladonna in childhood. Iran. J. Pediatr.; 2018; 28, e7865. [DOI: https://dx.doi.org/10.5812/ijp.7865]
79. Kwakye, G.F.; Jiménez, J.; Jiménez, J.A.; Aschner, M. Atropa belladonna neurotoxicity: Implications to neurological disorders. Food Chem. Toxicol.; 2018; 116, pp. 346-353. [DOI: https://dx.doi.org/10.1016/j.fct.2018.04.022]
80. Rastakhiz, N.; Azar, P.; Tehrani, M.; Moradalizadeh, M.; Larijani, K. Chemical constituents comparison of essential oils of aerial parts of Conium maculatum L. growing wild in Iran by hydrodistillation, microwave-assisted hydrodistillation and solid phase microextraction methods. Int. J. Life Sci.; 2015; 9, pp. 48-50. [DOI: https://dx.doi.org/10.3126/ijls.v9i2.12056]
81. Erenler, A.; Baydın, A.; Duran, L.; Yardan, T.; Türköz, B. A case of respiratory failure due to poison hemlock poisoning presented to an emergency department. Hong Kong J. Emerg. Med.; 2011; 18, pp. 235-238. [DOI: https://dx.doi.org/10.1177/102490791101800408]
82. Kulaksiz, F.; Erenler, A.; Ozden, H.; Ay, M.; Yastı, A. Hemlock poisoning in emergent patients. Glob. J. Rare Dis.; 2016; 1, pp. 004-006. [DOI: https://dx.doi.org/10.17352/2640-7876.000002]
83. Grosu, E.; Ichim, M. Turning Meadow Weeds Into Valuable Species for the Romanian Ethnomedicine While Complying With the Environmentally Friendly Farming Requirements of the European Union’s Common Agricultural Policy. Front. Pharmacol.; 2020; 1, 529. [DOI: https://dx.doi.org/10.3389/fphar.2020.00529] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32390852]
84. Bishayee, K.; Mukherjee, A.; Paul, A.; Khuda-Bukhsh, A. Homeopathic mother tincture of Conium initiates reactive oxygen species mediated DNA damage and makes HeLa cells prone to apoptosis. Tang Humanit. Med.; 2012; 2, pp. 26.1-26.5. [DOI: https://dx.doi.org/10.5667/tang.2012.0018]
85. Salem, M.; Mohamed, A.; Ali, H.; Farraj, D. Characterization of phytoconstituents from alcoholic extracts of four woody species and their potential uses for management of six Fusarium oxysporum isolates identified from some plant hosts. Plants; 2021; 10, 1325. [DOI: https://dx.doi.org/10.3390/plants10071325]
86. Madaan, R.; Kumar, S. Screening of alkaloidal fraction of Conium maculatum L. aerial parts for analgesic and antiinflammatory activity. Indian J. Pharm. Sci.; 2012; 74, 457. [DOI: https://dx.doi.org/10.4103/0250-474x.108423]
87. Heinle, H.; Tober, C.; Zhang, D.; Jaggi, R.; Kuebler, W. The low-dose combination preparation vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation. Clin. Hemorheol. Microcirc.; 2010; 46, pp. 23-35. [DOI: https://dx.doi.org/10.3233/CH-2010-1330]
88. Lee, S.; Green, B.; Welch, K.; Jordan, G.; Zhang, Q.; Panter, K.; Hughes, D.; Chang, C.-W.; Pfister, J.; Gardner, D. Stereoselective potencies and relative toxicities of γ-coniceine and n-methylconiine enantiomers. Chem. Res. Toxicol.; 2013; 26, pp. 616-621. [DOI: https://dx.doi.org/10.1021/tx400050r]
89. Green, B.; Lee, S.; Welch, K.; Pfister, J.; Panter, K. Fetal muscle-type nicotinic acetylcholine receptor activation in TE-671 cells and inhibition of fetal movement in a day 40 pregnant goat model by optical isomers of the piperidine alkaloid coniine. J. Pharmacol. Exp. Ther.; 2012; 344, pp. 295-307. [DOI: https://dx.doi.org/10.1124/jpet.112.199588]
90. Pallares, J.; Sabán, J.; Bouza, C.; Diaz, J.; Rodríguez, R.; Morena, J.; Liste, D.; Serrano-Rios, M. Reversible autonomic dysfunction in Oenanthe crocata poisoning evaluated by simple bedside tests. Hum. Toxicol.; 1985; 4, pp. 521-526. [DOI: https://dx.doi.org/10.1177/096032718500400508]
91. Banerjee, S.; Manisha, C.; Murugan, D.; Justin, A. Natural Products Altering GABAergic Transmission. Natural Medicinal Plants; IntechOpen: London, UK, 2022; [DOI: https://dx.doi.org/10.5772/intechopen.99500]
92. Ruekberg, B. A chemistry tidbit for batman fans. J. Chem. Educ.; 2010; 87, pp. 1017-1018. [DOI: https://dx.doi.org/10.1021/ed1003228]
93. Appendino, G.; Pollastro, F.; Verotta, L.; Ballero, M.; Romano, A.; Wyrembek, P.; Szczuraszek, K.; Mozrzymas, J.; Taglialatela-Scafati, O. Polyacetylenes from Sardinian Oenanthe fistulosa: A molecular clue to risus sardonicus. J. Nat. Prod.; 2009; 72, pp. 962-965. [DOI: https://dx.doi.org/10.1021/np8007717] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19245244]
94. Valente, J.; Zuzarte, M.; Gonçalves, M.; Lopes, M.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil. Food Chem. Toxicol.; 2013; 62, pp. 349-354. [DOI: https://dx.doi.org/10.1016/j.fct.2013.08.083]
95. Wyrembek, P.; Negri, R.; Kaczor, P.; Czyżewska, M.; Appendino, G.; Mozrzymas, J. Falcarindiol allosterically modulates GABAergic currents in cultured rat hippocampal neurons. J. Nat. Prod.; 2012; 75, pp. 610-616. [DOI: https://dx.doi.org/10.1021/np2008522]
96. Mitchell, M.; Routledge, P. Hemlock water dropwort poisoning—A review. Clin. Toxicol.; 1978; 12, pp. 417-426. [DOI: https://dx.doi.org/10.3109/15563657809150012]
97. Ai, T.; Phien, H.; Men, T. Phytochemical constituents and toxicity of the ethanol extract of Ricinus communis (L.) in Drosophila melanogaster. Asian J. Biol.; 2021; 13, pp. 12-21. [DOI: https://dx.doi.org/10.9734/ajob/2021/v13i430192]
98. Pelat, T.; Hust, M.; Hale, M.; Lefranc, M.; Dübel, S.; Thullier, P. Isolation of a human-like antibody fragment (SCFV) that neutralizes ricin biological activity. BMC Biotechnol.; 2009; 9, 60. [DOI: https://dx.doi.org/10.1186/1472-6750-9-60]
99. Chouhan, H.; Swarnakar, G.; Jogpal, B. Medicinal Properties of Ricinus communis: A Review. Int. J. Pharm. Sci. Res.; 2021; 12, pp. 3632-3642. [DOI: https://dx.doi.org/10.13040/ijpsr.0975-8232.12(7).3632-42]
100. Istaufa, F.; Subagio, Y.; Suswati, I. Castor plant (Ricinus communis L.) leaf extract as potential antibacterial against the growth of Mycobacterium tuberculosis. Folia Medica Indones.; 2022; 58, pp. 371-376. [DOI: https://dx.doi.org/10.20473/fmi.v58i4.29307]
101. Worbs, S.; Köhler, K.; Pauly, D.; Avondet, M.; Schaer, M.; Dorner, M.; Dorner, B. Ricinus communis intoxications in human and veterinary medicine—A summary of real cases. Toxins; 2011; 3, pp. 1332-1372. [DOI: https://dx.doi.org/10.3390/toxins3101332]
102. Citores, L.; Ferreras, J.; Iglesias, R.; Carbajales, M.; Arias, F.; Jiménez, P.; Rojo, M.; Girbes, T. Molecular mechanism of inhibition of mammalian protein synthesis by some four-chain agglutinins. FEBS Lett.; 1993; 329, pp. 59-62. [DOI: https://dx.doi.org/10.1016/0014-5793(93)80193-X] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8354410]
103. Cruz, R.; Pastor, A.; Delgado-García, J. The neurotoxic effects of Ricinus communis agglutinin-II. J. Toxicol. Toxin Rev.; 1995; 14, pp. 1-46. [DOI: https://dx.doi.org/10.3109/15569549509089967]
104. Almehmady, A.M.; Alhakamy, N.A.; Alharbi, W.S. Screening of Herbal Medicines for Neurotoxicity: Principles and Methods. Medicinal Herbs and Fungi; Springer: Singapore, 2021; 355. [DOI: https://dx.doi.org/10.1007/978-981-33-4141-8_10]
105. Williamson, E.M. Herbal Neurotoxicity: An Introduction to Its Occurrence and Causes. Toxicology of Herbal Products; Pelkonen, O.; Duez, P.; Vuorela, P.; Vuorela, H. Springer Int. Publ.: Cham, Switzerland, 2017; pp. 345-362. [DOI: https://dx.doi.org/10.1007/978-3-319-43806-1_14]
106. Milanlioglu, A. Toxic encephalopathy after Atropa belladonna poisoning. Pak. J. Med. Sci.; 2011; 27, pp. 926-928.
107. Radulović, N.; Đorđević, N.; Denić, M.; Pinheiro, M.M.G.; Fernandes, P.D.; Boylan, F. A novel toxic alkaloid from poison hemlock (Conium maculatum L., Apiaceae): Identification, synthesis and antinociceptive activity. Food Chem. Toxicol.; 2012; 50, pp. 274-279. [DOI: https://dx.doi.org/10.1016/j.fct.2011.10.060]
108. Sharma, S.; Raina, A.; Agrawal, D.C.; Dhar, M.K.; Kaul, S. Neurotoxic Medicinal Plants of Indian Himalayan Regions: An Overview. Medicinal Herbs and Fungi; Springer: Singapore, 2021; pp. 469-493. [DOI: https://dx.doi.org/10.1007/978-981-33-4141-8_19]
109. Kharchoufa, L.; Merrouni, I.A.; Yamani, A.; Elachouri, M. Profile on medicinal plants used by the people of North Eastern Morocco: Toxicity Concerns. Toxicon; 2018; 154, pp. 90-113. [DOI: https://dx.doi.org/10.1016/j.toxicon.2018.09.003]
110. Singh, R.; Tiwari, P.; Sharma, B.; Guerrero-Perilla, C.; Coy-Barrera, E. Analysis of polyacetylenes. Recent Advances in Natural Products Analysis; Elsevier: Amsterdam, The Netherlands, 2020; pp. 707-722. [DOI: https://dx.doi.org/10.1016/B978-0-12-816455-6.00023-8]
111. Orlando-Goulart, C.F.; Welch, K.D.; Pfister, J.A.; Goulart, D.S.; Damasceno, A.D.; Lee, S.T. Neurobehavioral evaluation of mice dosed with water hemlock green seeds and tubers. Poisonous Plant Res. PPR; 2018; 1, pp. 1-13. [DOI: https://dx.doi.org/10.26077/sk8v-xz71]
112. Welch, K.D.; Stonecipher, C.A.; Lee, S.T.; Cook, D. The acute toxicity of water hemlock (Cicuta douglasii) in a goat model. Toxicon; 2020; 176, pp. 55-58. [DOI: https://dx.doi.org/10.1016/j.toxicon.2020.02.010]
113. Gal, Y.; Sapoznikov, A.; Lazar, S.; Shoseyov, D.; Aftalion, M.; Gutman, H.; Evgy, Y.; Gez, R.; Nevo, R.; Falach, R. Long-Term Pulmonary Damage in Surviving Antitoxin-Treated Mice following a Lethal Ricin Intoxication. Toxins; 2024; 16, 103. [DOI: https://dx.doi.org/10.3390/toxins16020103]
114. Franke, H.; Scholl, R.; Aigner, A. Ricin and Ricinus communis in pharmacology and toxicology-from ancient use and “Papyrus Ebers” to modern perspectives and “poisonous plant of the year 2018”. Naunyn-Schmiedeberg’s Arch. Pharmacol.; 2019; 392, pp. 1181-1208. [DOI: https://dx.doi.org/10.1007/s00210-019-01691-6]
115. Jung, H.; Son, H.; Jin, G.; Park, Y. Preventive role of PD-1 on MPTP-induced dopamine depletion in mice. Cell. Biochem. Funct.; 2010; 28, pp. 217-223. [DOI: https://dx.doi.org/10.1002/cbf.1642]
116. Khazdair, M.; Kianmehr, M.; Anaeigoudari, A. Effects of medicinal plants and flavonoids on Parkinson’s disease, a review on basic and clinical evidences. Adv. Pharm. Bull.; 2020; 11, pp. 224-232. [DOI: https://dx.doi.org/10.34172/apb.2021.026] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33880344]
117. Lopez, M.; Dempsey, R.; Vemuganti, R. Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem. Int.; 2015; 89, pp. 75-82. [DOI: https://dx.doi.org/10.1016/j.neuint.2015.08.009] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26277384]
118. Mani, R.; Sulthana, A.; Muthusamy, G.; Elangovan, N. Progress in the development of naturally derived active metabolites-based drugs: Potential therapeutics for Alzheimer’s disease. Biotechnol. Appl. Biochem.; 2022; 69, pp. 2713-2732. [DOI: https://dx.doi.org/10.1002/bab.2317] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35067971]
119. Al-Snafi, A. Medicinal plants with neuroprotective effects. GSC Biol. Pharm. Sci.; 2021; 17, pp. 213-231. [DOI: https://dx.doi.org/10.30574/gscbps.2021.17.1.0319]
120. Sharifi-Rad, M.; Lankatillake, C.; Dias, D.; Docea, A.; Mahomoodally, M.; Lobine, D.; Chazot, P.; Kurt, B.; Tumer, T.; Moreira, A. et al. Impact of natural compounds on neurodegenerative disorders: From preclinical to pharmacotherapeutics. J. Clin. Med.; 2020; 9, 1061. [DOI: https://dx.doi.org/10.3390/jcm9041061]
121. Sharma, N.; Tan, M.; An, S. Mechanistic aspects of Apiaceae family spices in ameliorating Alzheimer’s disease. Antioxidants; 2021; 10, 1571. [DOI: https://dx.doi.org/10.3390/antiox10101571]
122. Moura, M. Neuroprotective effects of crude extracts, compounds, and isolated molecules obtained from plants in the central nervous system injuries: A systematic review. Front. Neurosci.; 2023; 17, 1249685. [DOI: https://dx.doi.org/10.3389/fnins.2023.1249685]
123. He, X.; Zhou, Y.; Sheng, S.; Li, J.; Wang, G.; Zhang, F. Ellagic acid protects dopamine neurons via inhibition of NLRP3 inflammasome activation in microglia. Oxidative Med. Cell. Longev.; 2020; 2020, 2963540. [DOI: https://dx.doi.org/10.1155/2020/2963540]
124. Ansari, M.; Abdul, H.; Joshi, G.; Opii, W.; Butterfield, D. Protective effect of quercetin in primary neurons against aβ(1–42): Relevance to Alzheimer’s disease. J. Nutr. Biochem.; 2009; 20, pp. 269-275. [DOI: https://dx.doi.org/10.1016/j.jnutbio.2008.03.002]
125. Tian, J.; Wang, X.; Tian, Z. Focusing on formononetin: Recent perspectives for its neuroprotective potentials. Front. Pharmacol.; 2022; 13, 905898. [DOI: https://dx.doi.org/10.3389/fphar.2022.905898]
126. Krasieva, T.; Ehren, J.; O’Sullivan, T.; Tromberg, B.; Maher, P. Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy. Neurochem. Int.; 2015; 89, pp. 243-248. [DOI: https://dx.doi.org/10.1016/j.neuint.2015.08.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26271433]
127. Liu, Y.; Yu, H.; Wang, Y.; Tian, T.; Wu, W.; Zhou, M.; Meng, X.; Ruan, H. Neuroprotective lignans from the fruits of Schisandra bicolor var. tuberculata. J. Nat. Prod.; 2017; 80, pp. 1117-1124. [DOI: https://dx.doi.org/10.1021/acs.jnatprod.7b00035] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28333453]
128. Yu, H.; Chen, Z.; Sun, B.; Liu, J.; Meng, F.; Liu, Y.; Tian, T.; Jin, A.; Ruan, H. Lignans from the fruit of Schisandra glaucescens with antioxidant and neuroprotective properties. J. Nat. Prod.; 2014; 77, pp. 1311-1320. [DOI: https://dx.doi.org/10.1021/np4010536] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24927000]
129. Qu, Z.; Zhou, Y.; Zeng, Y.; Lin, Y.; Li, Y.; Zhong, Z.; Chan, W. Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat. PLoS ONE; 2012; 7, e29641. [DOI: https://dx.doi.org/10.1371/journal.pone.0029641]
130. Xu, J.; Wang, F.; Guo, J.; Xu, C.; Cao, Y.; Fang, Z.; Wang, Q. Pharmacological mechanisms underlying the neuroprotective effects of Alpinia oxyphylla Miq. on Alzheimer’s disease. Int. J. Mol. Sci.; 2020; 21, 2071. [DOI: https://dx.doi.org/10.3390/ijms21062071]
131. Yu, S.; Liu, M.; Gu, X.; Ding, F. Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation. Cell. Mol. Neurobiol.; 2008; 28, pp. 1067-1078. [DOI: https://dx.doi.org/10.1007/s10571-008-9284-z]
132. Bozorgi, M.; Najafi, Z.; Omidpanah, S.; Sadri, A.; Narimani, Z.; Moghadam, F.; Edraki, N.; Akbarzadeh, T.; Saeedi, M. Investigation of anti-Alzheimer’s activity of aqueous extract of Areca nuts (Areca catechu L.): In vitro and in vivo studies. Bol. Latinoam. Caribe Plantas Med. Aromat.; 2021; 20, pp. 406-415. [DOI: https://dx.doi.org/10.37360/blacpma.21.20.4.30]
133. Sun, A.; Wang, Q.; Simonyi, Á.; Sun, G. Botanical phenolics and brain health. Neuromol. Med.; 2008; 10, pp. 259-274. [DOI: https://dx.doi.org/10.1007/s12017-008-8052-z]
134. Lu, Y.; Guo, M.; Zhang, Y.; Yu, L.; Wu, J.; Tang, Y.; Ai, W.; Zhu, F.; Law, B.; Chen, Q. et al. Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: Current evidence, advances, and opportunities. Oxidative Med. Cell. Longev.; 2022; 2022, 5288698. [DOI: https://dx.doi.org/10.1155/2022/5288698]
135. Mohsenpour, H.; Pesce, M.; Patruno, A.; Bahrami, A.; Pour, P.; Farzaei, M. A review of plant extracts and plant-derived natural compounds in the prevention/treatment of neonatal hypoxic-ischemic brain injury. Int. J. Mol. Sci.; 2021; 22, 833. [DOI: https://dx.doi.org/10.3390/ijms22020833]
136. Zain, M.; Shamsuddin, N.; Noorden, M. The effects of Centella asiatica extract (CAE) on methamphetamine-induced neurotoxicity via human neuroblastoma cell line. ASM Sci. J.; 2021; 16, pp. 1-9. [DOI: https://dx.doi.org/10.32802/asmscj.2021.907]
137. Bandopadhyay, S.; Mandal, S.; Ghorai, M.; Jha, N.; Kumar, M.; Radha,; Ghosh, A.; Prockow, J.; Lastra, J.; Dey, A. Therapeutic properties and pharmacological activities of asiaticoside and madecassoside: A review. J. Cell. Mol. Med.; 2023; 27, pp. 593-608. [DOI: https://dx.doi.org/10.1111/jcmm.17635] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36756687]
138. Kim, Y. Neuroprotective phenolics in medicinal plants. Arch. Pharmacal Res.; 2010; 33, pp. 1611-1632. [DOI: https://dx.doi.org/10.1007/s12272-010-1011-x]
139. Tran, N. Neuroprotective potential of pyranocoumarins from Angelica gigas Nakai on glutamate-induced hippocampal cell death. Antioxidants; 2023; 12, 1651. [DOI: https://dx.doi.org/10.3390/antiox12081651]
140. Carrera, I.; Cacabelos, R. Current drugs and potential future neuroprotective compounds for Parkinson’s disease. Curr. Neuropharmacol.; 2019; 17, pp. 295-306. [DOI: https://dx.doi.org/10.2174/1570159X17666181127125704]
141. Al-Khazaleh, A. The neurotherapeutic arsenal in Cannabis sativa: Insights into anti-neuroinflammatory and neuroprotective activity and potential entourage effects. Molecules; 2024; 29, 410. [DOI: https://dx.doi.org/10.3390/molecules29020410]
142. Shimizu, H.; Koyama, T.; Yamada, S.; Lipton, S.; Satoh, T. Zonarol, a sesquiterpene from the brown algae Dictyopteris undulata, provides neuroprotection by activating the NRF2/are pathway. Biochem. Biophys. Res. Commun.; 2015; 457, pp. 718-722. [DOI: https://dx.doi.org/10.1016/j.bbrc.2015.01.059]
143. Xu, W.; Li, R.; Quasie, O.; Yang, M.; Kong, L.; Luo, J. Polyprenylated tetraoxygenated xanthones from the roots of Hypericum monogynum and their neuroprotective activities. J. Nat. Prod.; 2016; 79, pp. 1971-1981. [DOI: https://dx.doi.org/10.1021/acs.jnatprod.6b00251]
144. Piccialli, I.; Tedeschi, V.; Caputo, L.; Amato, G.; Martino, L.; Feo, V.; Secondo, A.; Pannaccione, A. The antioxidant activity of limonene counteracts neurotoxicity triggered by AΒ1–42 oligomers in primary cortical neurons. Antioxidants; 2021; 10, 937. [DOI: https://dx.doi.org/10.3390/antiox10060937]
145. Rawa, M.; Mazlan, M.; Ahmad, R.; Nogawa, T.; Wahab, H. Roles of Syzygium in anti-cholinesterase, anti-diabetic, anti-inflammatory, and antioxidant: From Alzheimer’s perspective. Plants; 2022; 11, 1476. [DOI: https://dx.doi.org/10.3390/plants11111476]
146. Elufioye, T.; Berida, T.; Habtemariam, S. Plants-derived neuroprotective agents: Cutting the cycle of cell death through multiple mechanisms. Evid.-Based Complement. Altern. Med.; 2017; 2017, 3574012. [DOI: https://dx.doi.org/10.1155/2017/3574012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28904554]
147. Caputo, L.; Amato, G.; Martino, L.; Feo, V.; Nazzaro, F. Anti-cholinesterase and anti-α-amylase activities and neuroprotective effects of carvacrol and p-cymene and their effects on hydrogen peroxide-induced stress in SH-SY5Y cells. Int. J. Mol. Sci.; 2023; 24, 6073. [DOI: https://dx.doi.org/10.3390/ijms24076073] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37047044]
148. Parasram, K. Flavonoids and diarylheptanoids: Neuroprotective activities of phytochemicals. Int. J. Pharmacol. Phytochem. Ethnomed.; 2017; 6, pp. 82-86. [DOI: https://dx.doi.org/10.18052/www.scipress.com/IJPPE.6.82]
149. Omoruyi, S.; Ibrakaw, A.; Ekpo, O.; Boatwright, J.; Cupido, C.; Hussein, A. Neuroprotective activities of Crossyne flava bulbs and Amaryllidaceae alkaloids: Implications for Parkinson’s disease. Molecules; 2021; 26, 3990. [DOI: https://dx.doi.org/10.3390/molecules26133990]
150. Zhao, L.; Chen, Q.; Brinton, R. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp. Biol. Med.; 2002; 227, pp. 509-519. [DOI: https://dx.doi.org/10.1177/153537020222700716]
151. Oluwatunase, G.; Enemali, F.; Okwute, P.; Asafa, O.; Ajimoh, F. Comparative study of the effect of Ginkgo biloba extract and Vitamin C on lead-induced hippocampal toxicity in adult male Wistar rats. Anat. J. Afr.; 2023; 12, pp. 2327-2336. [DOI: https://dx.doi.org/10.4314/aja.v12i1.9]
152. Pilija, V.; Radenković, M.; Brenesel, M.; Popović, M.; Ivetic, V.; Trivić, S. Inhibitory effect of Ginkgo biloba extract on the tonus 1250 of the small intestine and the colon of rabbits. Molecules; 2010; 15, pp. 2079-2086. [DOI: https://dx.doi.org/10.3390/molecules15042079]
153. Mazza, M.; Capuano, A.; Bria, P.; Mazza, S. Ginkgo biloba and donepezil: A comparison in the treatment of Alzheimer’s dementia in a randomized placebo-controlled double-blind study. Eur. J. Neurol.; 2006; 13, pp. 981-985. [DOI: https://dx.doi.org/10.1111/j.1468-1331.2006.01409.x]
154. Nikmahzar, E.; Jahanshahi, M.; Babakordi, F. Ginkgo biloba extract decreases scopolamine-induced congophilic amyloid plaques accumulation in male rat’s brain. Jundishapur J. Nat. Pharm. Prod.; 2018; 13, e69143. [DOI: https://dx.doi.org/10.5812/jjnpp.69143]
155. Brunetti, L.; Orlando, G.; Menghini, L.; Ferrante, C.; Chiavaroli, A.; Vacca, M. Ginkgo biloba leaf extract reverses amyloid β-peptide-induced isoprostane production in rat brain in vitro. Planta Medica; 2006; 72, pp. 1296-1299. [DOI: https://dx.doi.org/10.1055/s-2006-951688]
156. Nathan, P.; Ricketts, E.; Wesnes, K.; Mrazek, L.; Greville, W.; Stough, C. The acute nootropic effects of Ginkgo biloba in healthy older human subjects: A preliminary investigation. Hum. Psychopharmacol. Clin. Exp.; 2002; 17, pp. 45-49. [DOI: https://dx.doi.org/10.1002/hup.353] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12404706]
157. Niederhofer, H. Ginkgo biloba treating patients with attention-deficit disorder. Phytother. Res.; 2009; 24, pp. 26-27. [DOI: https://dx.doi.org/10.1002/ptr.2854] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19441138]
158. Brinkley, T.; Lovato, J.; Arnold, A.; Furberg, C.; Kuller, L.; Burke, G.; Nahin, R.; Lopez, O.; Yasar, S.; Williamson, J. Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am. J. Hypertens.; 2010; 23, pp. 528-533. [DOI: https://dx.doi.org/10.1038/ajh.2010.14]
159. Helal, N.; Ibrahim, F.; Safia, H.; Shamy, A.; Ibrahim, H.; AboHashish, N.; Elbastawesy, S. The nephrotoxic effect of chloroquine, the off-label anti-COVID 19 and possible protective role of Ginkgo biloba extract in male albino rats. Egypt. J. Forensic Sci. Appl. Toxicol.; 2023; 23, pp. 49-59. [DOI: https://dx.doi.org/10.21608/ejfsat.2022.129587.1255]
160. Hashiguchi, M.; Ohta, Y.; Shimizu, M.; Maruyama, J.; Mochizuki, M. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. J. Pharm. Health Care Sci.; 2015; 1, 14. [DOI: https://dx.doi.org/10.1186/s40780-015-0014-7]
161. Johnson, W.; Bergfeld, W.; Belsito, D.; Hill, R.; Klaassen, C.; Liebler, D.; Marks, J.; Shank, R.; Slaga, T.; Snyder, P. et al. Safety assessment of Centella asiatica-derived ingredients as used in cosmetics. Int. J. Toxicol.; 2023; 42, pp. 5S-22S. [DOI: https://dx.doi.org/10.1177/10915818231158272]
162. Setyaningsih, W.; Arfian, N.; Fitriawan, A.; Yuniartha, R.; Sari, D. Ethanolic extract of Centella asiatica treatment in the early stage of hyperglycemia condition inhibits glomerular injury and vascular remodeling in diabetic rat model. Evid.-Based Complement. Altern. Med.; 2021; 2021, 6671130. [DOI: https://dx.doi.org/10.1155/2021/6671130]
163. Gupta, R.; Flora, S. Effect of Centella asiatica on arsenic induced oxidative stress and metal distribution in rats. J. Appl. Toxicol.; 2006; 26, pp. 213-222. [DOI: https://dx.doi.org/10.1002/jat.1131]
164. Widiyastuti, T. The effect of Centella asiatica extract in zebrafish (Danio rerio) larvae as a chronic constant hypoxia (CCH) model. Pediatr. Sci. J.; 2022; 1, pp. 20-26. [DOI: https://dx.doi.org/10.51559/pedscij.v1i1.5]
165. Choi, M.; Zheng, H.; Kim, J.; Lee, K.; Park, Y.; Lee, D. Protective effects of Centella asiatica leaf extract on dimethylnitrosamine-induced liver injury in rats. Mol. Med. Rep.; 2016; 14, pp. 4521-4528. [DOI: https://dx.doi.org/10.3892/mmr.2016.5809]
166. Kuswati, K. The effect of Centella asiatica ethanolic extract on caspase-3 expression in prefrontal cortex of chronic restraint stress induced Sprague Dawley rat. J. Kedokt. Dan Kesehat. Indones.; 2015; 7, pp. 65-72. [DOI: https://dx.doi.org/10.20885/JKKI.Vol7.Iss2.art6]
167. Ariani, A. Centella asiatica extract ameliorates deoxygenation-induced neurological dysfunction in zebrafish larvae. Open Vet. J.; 2024; 14, 1154. [DOI: https://dx.doi.org/10.5455/OVJ.2024.v14.i5.9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/38938421]
168. KK, A. Centella asiatica (L.) urban: A review on panoramic exploration of medicinal marvels for health and healing. Int. J. Adv. Acad. Stud.; 2020; 2, pp. 369-372. [DOI: https://dx.doi.org/10.33545/27068919.2020.v2.i1f.1077]
169. Hussin, H.; Lawi, M.; Haflah, N.; Kassim, A.; Idrus, R.; Lokanathan, Y. Centella asiatica (L.)-neurodifferentiated mesenchymal stem cells promote the regeneration of peripheral nerve. Tissue Eng. Regen. Med.; 2020; 17, pp. 237-251. [DOI: https://dx.doi.org/10.1007/s13770-019-00235-6]
170. Roushan, R.; Tiwari, S.; Ayurveda, P.; Sansthan, C. Response of Centella asiatica in the management of age-related problems among elderly with special reference to cognitive problems as per Prakriti. Int. J. Res. Ayurveda Pharm.; 2013; 4, pp. 163-167. [DOI: https://dx.doi.org/10.7897/2277-4343.04215]
171. Kannoor, A.; Ramani, P. Effect of ethanolic extract of Centella asiatica on pentylene tetrazol induced seizure in albino mice. Int. J. Basic Clin. Pharmacol.; 2020; 9, 1583. [DOI: https://dx.doi.org/10.18203/2319-2003.ijbcp20204101]
172. Jiang, H.; Zheng, G.; Lv, J.; Chen, H.; Lin, J.; Fan, G.; Ding, X. Identification of Centella asiatica’s effective ingredients for inducing the neuronal differentiation. Evid.-Based Complement. Altern. Med.; 2016; 2016, 9634750. [DOI: https://dx.doi.org/10.1155/2016/9634750]
173. Xiang, Y.; Shang, H.; Gao, X.; Zhang, B. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother. Res.; 2008; 22, pp. 851-858. [DOI: https://dx.doi.org/10.1002/ptr.2384]
174. Huang, X.; Li, N.; Pu, Y.; Zhang, T.; Bing, W. Neuroprotective effects of Ginseng phytochemicals: Recent perspectives. Molecules; 2019; 24, 2939. [DOI: https://dx.doi.org/10.3390/molecules24162939]
175. Boța, M.; Vlaia, L.; Jîjie, A.R.; Marcovici, I.; Crişan, F.; Oancea, C.; Dehelean, C.A.; Mateescu, T.; Moacă, E.A. Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer. Pharmaceuticals; 2024; 17, 598. [DOI: https://dx.doi.org/10.3390/ph17050598]
176. Kim, K.; Lee, D.; Lee, H.; Kim, C.; Jung, K.; Kang, K. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions. J. Ginseng Res.; 2018; 42, pp. 239-247. [DOI: https://dx.doi.org/10.1016/j.jgr.2017.03.011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29989012]
177. Dik, B.; Avci, O.; Dik, I. In vitro antiviral and antioxidant activities of silymarin and Panax ginseng on vero cells infected with bovine ephemeral fever virus and blue tongue virus. Acta Pol. Pharm.-Drug Res.; 2019; 76, pp. 291-297. [DOI: https://dx.doi.org/10.32383/appdr/96330] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17135776]
178. Tan, X.; Gu, J.; Zhao, B.; Wang, S.; Yuan, J.; Wang, C.; Chen, J.; Liu, J.; Feng, L.; Jia, X. Ginseng improves cognitive deficit via the rage/NF-ΚB pathway in advanced glycation end product-induced rats. J. Ginseng Res.; 2015; 39, pp. 116-124. [DOI: https://dx.doi.org/10.1016/j.jgr.2014.09.002]
179. Gong, L.; Yin, J.; Ren, H.; Lou, Y.; Jiang, H.; Sun, L.; Jia, J.; Zeng, X. Neuroprotective mechanisms of Ginsenoside RB1 in central nervous system diseases. Front. Pharmacol.; 2022; 13, 914352. [DOI: https://dx.doi.org/10.3389/fphar.2022.914352]
180. Lee, S.; Chu, K.; Sim, J.; Heo, J.; Kim, M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis. Assoc. Disord.; 2008; 22, pp. 222-226. [DOI: https://dx.doi.org/10.1097/WAD.0b013e31816c92e6]
181. Mahour, K. Mercury retention after Panax ginseng treatment against mercuric chloride intoxication in hepato-haemato indices in albino rats. World J. Biol. Pharm. Health Sci.; 2023; 13, pp. 345-349. [DOI: https://dx.doi.org/10.30574/wjbphs.2023.13.2.0113]
182. Yang, K.; Ryu, T.; Chung, B. A meta-analysis of preclinical studies to investigate the effect of Panax ginseng on alcohol-associated liver disease. Antioxidants; 2023; 12, 841. [DOI: https://dx.doi.org/10.3390/antiox12040841]
183. Cristina-Souza, G.; Santos-Mariano, A.; Lima-Silva, A.; Costa, P.; Domingos, P.; Silva, S.; Abreu, W.; De-Oliveira, F.; Osiecki, R. Panax ginseng supplementation increases muscle recruitment, attenuates perceived effort, and accelerates muscle force recovery after an eccentric-based exercise in athletes. J. Strength Cond. Res.; 2020; 36, pp. 991-997. [DOI: https://dx.doi.org/10.1519/JSC.0000000000003555]
184. Singh, M.; Jayant, K.; Singh, D.; Bhutani, S.; Poddar, N.; Chaudhary, A.; Khan, S.; Adnan, M.; Siddiqui, A.; Hassan, M. et al. Withania somnifera (L.) dunal (ashwagandha) for the possible therapeutics and clinical management of SARS-COV-2 infection: Plant-based drug discovery and targeted therapy. Front. Cell. Infect. Microbiol.; 2022; 12, 933824. [DOI: https://dx.doi.org/10.3389/fcimb.2022.933824]
185. Sankar, S.; Manivasagam, T.; Krishnamurti, A.; Ramanathan, M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: An analysis of behavioral and biochemical variables. Cell. Mol. Biol. Lett.; 2007; 12, pp. 473-481. [DOI: https://dx.doi.org/10.2478/s11658-007-0015-0]
186. Sandhu, J.; Shah, B.; Shenoy, S.; Chauhan, S.; Lavekar, G.; Padhi, M. Effects of Withania somnifera (ashwagandha) and Terminalia arjuna (arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int. J. Ayurveda Res.; 2010; 1, 144. [DOI: https://dx.doi.org/10.4103/0974-7788.72485] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21170205]
187. Zaid, M.; Chauhan, M.; Chauhan, S. Protective role of Withania somnifera root extract on lipid peroxidation of erythrocytes. Univ. J. Phytochem. Ayurvedic Heights; 2022; II, pp. 1-8. [DOI: https://dx.doi.org/10.51129/ujpah-2022-33-2(1)] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/39364798]
188. Nakajima, H.; Wakabayashi, Y.; Wakamatsu, K.; Imokawa, G. An extract of Withania somnifera attenuates endothelin-1-stimulated pigmentation in human epidermal equivalents through the interruption of PKC activity within melanocytes. Phytother. Res.; 2011; 25, pp. 1398-1411. [DOI: https://dx.doi.org/10.1002/ptr.3552]
189. Chaudhari, K.; Tiwari, R.; Chaudhari, S.; Joshi, S.; Singh, H. Withania somnifera as an adjunctive treatment for refractory restless legs syndrome in Parkinson’s disease: A case report. Cureus; 2021; 13, e20775. [DOI: https://dx.doi.org/10.7759/cureus.20775]
190. Pingali, U.; Pilli, R.; Fatima, N. Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacogn. Res.; 2014; 6, pp. 12-18. [DOI: https://dx.doi.org/10.4103/0974-8490.122912]
191. Basudkar, V. Emerging vistas for the nutraceutical Withania somnifera in inflammaging. Pharmaceuticals; 2024; 17, 597. [DOI: https://dx.doi.org/10.3390/ph17050597]
192. Seth, S.; Agarwal, K.; Rahman, A. Curcumin: A review of its effects on human health. Int. Healthc. Res. J.; 2022; 5, pp. RV1-RV4. [DOI: https://dx.doi.org/10.26440/IHRJ/0510.01486]
193. Han, S.; Xu, J.; Guo, X.; Huang, M. Curcumin ameliorates severe influenza pneumonia via attenuating lung injury and regulating macrophage cytokines production. Clin. Exp. Pharmacol. Physiol.; 2017; 45, pp. 84-93. [DOI: https://dx.doi.org/10.1111/1440-1681.12848]
194. Tomeh, M.; Hadianamrei, R.; Zhao, X. A review of curcumin and its derivatives as anticancer agents. Int. J. Mol. Sci.; 2019; 20, 1033. [DOI: https://dx.doi.org/10.3390/ijms20051033]
195. Huang, Q.; Zhang, C.; Qu, S.; Dong, S.; Ma, Q.; Hao, Y.; Liu, Z.; Wang, S.; Zhao, H.; Shi, Y. Chinese Herbal Extracts Exert Neuroprotective Effect in Alzheimer’s Disease Mouse Through the Dopaminergic Synapse/Apoptosis Signaling Pathway. Front. Pharmacol.; 2022; 13, 817213. [DOI: https://dx.doi.org/10.3389/fphar.2022.817213]
196. Paek, S.; Han, S.; Mun, S. Effects of Curcuma longa on status epilepticus induced by pilocarpine in rats. Int. J. Clin. Exp. Physiol.; 2023; 9, pp. 112-114. [DOI: https://dx.doi.org/10.5530/ijcep.2022.9.3.26]
197. Zeng, L.; Yang, T.; Yang, K.; Yu, G.; Li, J.; Xiang, W.; Chen, H. Efficacy and safety of curcumin and Curcuma longa extract in the treatment of arthritis: A systematic review and meta-analysis of randomized controlled trial. Front. Immunol.; 2022; 13, 891822. [DOI: https://dx.doi.org/10.3389/fimmu.2022.891822]
198. Akhter, Q.; Nahar, S. Cardioprotective effect of Curcuma longa (turmeric) on serum cardiac marker enzymes in isoproterenol induced myocardial infarction in rats. World J. Adv. Res. Rev.; 2022; 13, pp. 98-103. [DOI: https://dx.doi.org/10.30574/wjarr.2022.13.3.0201]
199. Nowak, A.; Kojder, K.; Zielonka-Brzezicka, J.; Wróbel, J.; Bosiacki, M.; Fabianska, M.; Wrobel, M.; Solek-Pastuszka, J.; Klimowicz, A. The Use of Ginkgo biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease. Front Pharmacol; 2021; 12, 775034. [DOI: https://dx.doi.org/10.3389/fphar.2021.775034]
200. Kandiah, N.; Ong, P.A.; Yuda, T.; Ng, L.L.; Mamun, K.; Merchant, R.A.; Chen, C.; Dominguez, J.; Marasigan, S.; Ampil, E. et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. CNS Neurosci. Ther.; 2019; 25, pp. 288-298. [DOI: https://dx.doi.org/10.1111/cns.13095]
201. Montes, P.; Ruiz-Sanchez, E.; Rojas, C.; Rojas, P. Ginkgo biloba extract 761: A review of basic studies and potential clinical use in psychiatric disorders. CNS Neurol. Disord. Drug Targets Former. Curr. Drug Targets CNS Neurol. Disord.; 2015; 14, pp. 132-149. [DOI: https://dx.doi.org/10.2174/1871527314666150202151440]
202. El Tabaa, M.M.; Sokkar, S.S.; Ramadan, E.S.; Abd El Salam, I.Z.; Zaid, A. Neuroprotective role of Ginkgo biloba against cognitive deficits associated with Bisphenol A exposure: An animal model study. Neurochem. Int.; 2017; 108, pp. 199-212. [DOI: https://dx.doi.org/10.1016/j.neuint.2017.03.019]
203. Jana, U.; Sur, T.K.; Maity, L.N.; Debnath, P.K.; Bhattacharyya, D. A clinical study on the management of generalized anxiety disorder with Centella asiatica. Nepal Med. Coll. J.; 2010; 12, pp. 8-11.
204. Tabassum, R.; Vaibhav, K.; Shrivastava, P.; Khan, A.; Ahmed, M.; Javed, H.; Islam, F.; Ahmad, S.; Siddiqui, M.; Safhi, M. et al. Centella asiatica attenuates the neurobehavioral, neurochemical and histological changes in transient focal middle cerebral artery occlusion rats. Neurol. Sci.; 2013; 34, pp. 925-933. [DOI: https://dx.doi.org/10.1007/s10072-012-1163-1]
205. Amjad, S.; Umesalma, S. Protective Effect of Centella asiatica against Aluminium-Induced Neurotoxicity in Cerebral Cortex, Striatum, Hypothalamus and Hippocampus of Rat Brain- Histopathological, and Biochemical Approach. J. Mol. Biomark. Diagn.; 2015; 6, 1000212. [DOI: https://dx.doi.org/10.4172/2155-9929.1000212]
206. Boondam, Y.; Tantisira, M.H.; Tilokskulchai, K.; Tapechum, S.; Pakaprot, N. Acute enhancing effect of a standardized extract of Centella asiatica (ECa 233) on synaptic plasticity: An investigation via hippocampal long-term potentiation. Pharm. Biol.; 2021; 59, pp. 367-374. [DOI: https://dx.doi.org/10.1080/13880209.2021.1893348] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33789075]
207. Teerapattarakan, N.; Benya-Aphikul, H.; Tansawat, R.; Wanakhachornkrai, O.; Tantisira, M.; Rodsiri, R. Neuroprotective effect of a standardized extract of Centella asiatica ECa233 in rotenone-induced parkinsonism rats. Phytomedicine; 2018; 44, pp. 65-73. [DOI: https://dx.doi.org/10.1016/j.phymed.2018.04.028] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29895494]
208. Wanakhachornkrai, O.; Pongrakhananon, V.; Chunhacha, P.; Wanasuntronwong, A.; Vattanajun, A.; Tantisira, B.; Chanvorachote, P.; Tantisira, M. Neuritogenic effect of standardized extract of Centella asiatica ECa233 on human neuroblastoma cells. BMC Complement. Altern. Med.; 2013; 13, 204. [DOI: https://dx.doi.org/10.1186/1472-6882-13-204]
209. Jantwal, A.; Durgapal, S.; Upadhyay, J.; Rana, M.; Tariq, M.; Dhariwal, A.; Joshi, T. Centella asiatica. Naturally Occurring Chemicals against Alzheimer’s Disease; Academic Press: Cambridge, MA, USA, 2021; pp. 257-269. [DOI: https://dx.doi.org/10.1016/C2018-0-03965-1]
210. Khadrawy, Y.A.; Mourad, I.M.; Mohammed, H.S.; Noor, N.A.; Ezz, H.S.A. A study on the possible therapeutic role of Panax ginseng extract against a rat model of Parkinson’s disease induced by intrastriatal rotenone injection. Int. J. Clin. Exp. Med.; 2016; 9, pp. 3831-3841.
211. Zhao, H.; Li, Q.; Zhang, Z.; Pei, X.; Wang, J.; Li, Y. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res; 2009; 1256, pp. 111-122. [DOI: https://dx.doi.org/10.1016/j.brainres.2008.12.031]
212. Luo, H.; Hu, J.; Wang, Y.; Chen, Y.; Zhu, D.; Jiang, R.; Qiu, Z. In vivo and in vitro neuroprotective effects of Panax ginseng glycoproteins. Int. J. Biol. Macromol.; 2018; 113, pp. 607-615. [DOI: https://dx.doi.org/10.1016/j.ijbiomac.2018.02.015]
213. Sun, X.C.; Ren, X.F.; Chen, L.; Gao, X.Q.; Xie, J.X.; Chen, W.F. Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. J. Steroid Biochem. Mol. Biol.; 2016; 155, pp. 94-103. [DOI: https://dx.doi.org/10.1016/j.jsbmb.2015.09.040]
214. Lee, B.; Sur, B.; Oh, S. Neuroprotective effect of Korean Red Ginseng against single prolonged stress-induced memory impairments and inflammation in the rat brain associated with BDNF expression. J. Ginseng Res.; 2022; 46, pp. 435-443. [DOI: https://dx.doi.org/10.1016/j.jgr.2021.08.002]
215. Singh, M.; Ramassamy, C. In Vitro screening of neuroprotective activity of Indian medicinal plant Withania somnifera. J. Nutr. Sci.; 2017; 6, e54. [DOI: https://dx.doi.org/10.1017/jns.2017.48]
216. Pandey, A.; Bani, S.; Dutt, P.; Kumar Satti, N.; Avtar Suri, K.; Nabi Qazi, G. Multifunctional neuroprotective effect of Withanone, a compound from Withania somnifera roots in alleviating cognitive dysfunction. Cytokine; 2018; 102, pp. 211-221. [DOI: https://dx.doi.org/10.1016/j.cyto.2017.10.019]
217. Elhadidy, M.E.; Sawie, H.G.; Meguid, N.A.; Khadrawy, Y.A. Protective effect of ashwagandha (Withania somnifera) against neurotoxicity induced by aluminum chloride in rats. Asian Pac. J. Trop. Biomed.; 2018; 8, pp. 59-66. [DOI: https://dx.doi.org/10.4103/2221-1691.221139]
218. Alzoubi, K.H.; Al Hilo, A.S.; Al-Balas, Q.A.; El-Salem, K.; El-Elimat, T.; Alali, F.Q. Withania somnifera root powder protects againist post-traumatic stress disorder-induced memory impairment. Mol. Biol. Rep.; 2019; 46, pp. 4709-4715. [DOI: https://dx.doi.org/10.1007/s11033-019-04915-3] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31218539]
219. Auddy, B.; Hazra, J.; Mitra, A.; Abedon, B.; Ghosal, S. A standardized Withania somnifera extract significantly reduces stress related parameters in chronically stressed humans: A double blind randomized placebo controlled study. J. Am. Med.; 2008; 11, pp. 51-57.
220. Saleem, S.; Muhammad, G.; Hussain, M.A.; Altaf, M.; Bukhari, S.N.A. Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective. Iran. J. Basic Med. Sci.; 2020; 23, pp. 1501-1526. [DOI: https://dx.doi.org/10.22038/IJBMS.2020.44254.10378]
221. Rajakrishnan, V.; Viswanathan, P.; Rajasekharan, K.N.; Menon, V.P. Neuroprotective role of curcumin from Curcuma longa on ethanol-induced brain damage. Phytother. Res.; 1999; 13, pp. 571-574. [DOI: https://dx.doi.org/10.1002/(SICI)1099-1573(199911)13:7<571::AID-PTR494>3.0.CO;2-7]
222. Nam, S.M.; Choi, J.H.; Yoo, D.Y.; Kim, W.; Jung, H.Y.; Kim, J.W.; Yoo, M.; Lee, S.; Kim, C.; Yoon, Y. et al. Effects of curcumin (Curcuma longa) on learning and spatial memory as well as cell proliferation and neuroblast differentiation in adult and aged mice by upregulating brain-derived neurotrophic factor and CREB signaling. J. Med. Food; 2014; 17, pp. 641-649. [DOI: https://dx.doi.org/10.1089/jmf.2013.2965]
223. He, H.J.; Xiong, X.; Zhou, S.; Zhang, X.R.; Zhao, X.; Chen, L.; Xie, C.L. Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson’s models. Neurochem. Int.; 2022; 15, 105297. [DOI: https://dx.doi.org/10.1016/j.neuint.2022.105297]
224. Akter, F.; Haque, M.; Islam, J.; Rahaman, A.; Bhowmick, S.; Hossain, S. Chronic Administration of Curcuma longa Extract Improves Spatial Memory-Related Learning Ability in Aged Rats by Inhibiting Brain Cortico-Hippocampal Oxidative Stress and TNFα. Adv. Alzheimer’s Dis.; 2015; 4, pp. 78-89. [DOI: https://dx.doi.org/10.4236/aad.2015.43008]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Background: Plants have long been recognized for their potential to influence neurological health, with both neuroprotective and neurotoxic properties. This review explores the dual nature of plant-derived compounds and their impact on the human brain. Discussion: Numerous studies have highlighted the neuroprotective effects of various phytoconstituents, such as those found in Ginkgo biloba, Centella asiatica, Panax ginseng, Withania somnifera, and Curcuma longa. The neuroprotective compounds have demonstrated antioxidant, anti-inflammatory, and cognitive-enhancing properties, making them promising candidates for combating neurodegenerative diseases and improving brain function. Polyphenolic compounds, triterpenic acids, and specific phytocompounds like the ones from EGb 761 extract have shown interactions with key enzymes and receptors in the brain, leading to neuroprotective outcomes. However, this review also acknowledges the neurotoxic potential of certain plants, such as the Veratrum species, which contains steroidal alkaloids that can cause DNA damage and disrupt neurological function, or Atropa belladonna, which interfere with the normal functioning of the cholinergic system in the body, leading to a range of symptoms associated with anticholinergic toxicity. Conslusions: This review also emphasizes the need for further research to elucidate the complex mechanisms underlying the neuroprotective and neurotoxic effects of plant-derived compounds, as well as to identify novel phytoconstituents with therapeutic potential. Understanding the complex relationship between plants and the human brain is crucial for harnessing the benefits of neuroprotective compounds while mitigating the risks associated with neurotoxic substances. This review provides a comprehensive overview of the knowledge on the neurological properties of plants and highlights the importance of continued research in this field for the development of novel therapeutic strategies targeting brain health and neurological disorders.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Elena-Alina Moacă 2
; Predescu, Iasmina-Alexandra 2 ; Dehelean, Cristina Adriana 2 ; Hegheș, Alina 3 ; Vlad, Daliborca Cristina 4 ; Popescu, Roxana 5
; Vlad, Cristian Sebastian 6 1 Department of Clinical Pharmacology, The Doctoral School of Medicine, “Pius Brînzeu” County Emergency Clinical Hospital Timisoara, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania;
2 Department of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania;
3 Department II—Pharmaceutical Technology, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania; Formulation and Technology of Drugs Research Center, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania
4 Department IV—Department of Biochemistry and Pharmacology, Division of Pharmacology, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania;
5 Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania;
6 Department IV—Department of Biochemistry and Pharmacology, Division of Pharmacology, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 2nd Eftimie Murgu Square, 300041 Timisoara, Romania;